Related_disease,Pathogenic_gene,PTC_model,Species_source_of_PTC_model,Sequence_of_PTC_model,PTC_site,Origin_aa_and_codon_of_PTC_site,PTC_codon,Delivery_as_vector_or_IVT_tRNA,Delivery_method,Supplenmentary_information_of_delivery,aa_and_anticodon_of_origin_tRNA,aa_and_anticodon_of_sup-tRNA,rnacentral_ID_of_origin_tRNA,tRNAscan-SE_ID_of_origin_tRNA,Species_source_of_origin_tRNA,Sequence_of_origin_tRNA,Sequence_of_sup-tRNA,Alignment,E-Value,Score,Identities,Gaps,Ref_length,Engineered_aaRS,Reading_through_efficiency,Measuring_of_efficiency,Supplenmentary_information_of_Measurement,Reaction_system,Safety,Immunogenicity,Investigation,Citation
Model protein,,Nluc,Oplophorus gracilirostris,"Nluc(c.484G>T,c.486C>A)[ful length]","c.484G>T,c.486C>A","GGC, p.Gly162",UGA,IVT_tRNA,liposome,,Gly(GCC),Gly(UCA),URS00006ABCCE_9606,chr16.trna19,Homo sapiens,GCAUUGGUGGUUCAGUGGUAGAAUUCUCGCCU(GCC)AUGCGGGCGGCCGGGCUUCGAUUCCUGGCCAAUGCA,GCAUUGGUGGUUCAGUGGUAGAAUUCUCGCCU(UCA)AUGCGGGCGGCCGGGCUUCGAUUCCUGGCCAAUGCA,"Query  1 GCAUUGGUGGUUCAGUGGUAGAAUUCUCGCCUUCAAUGCGGGCGGCCGGGCUUCGAUUCCUGGCCAAUGCA 71
|||||||||||||||||||||||||||||||| | ||||||||||||||||||||||||||||||||||||
Sbjct  1 GCAUUGGUGGUUCAGUGGUAGAAUUCUCGCCUGCCAUGCGGGCGGCCGGGCUUCGAUUCCUGGCCAAUGCA 71",,,71/71(100%),3/71(4.23%),71,NAN,0.908,absolute expression,,HEK293,low risk,not discussed,Screening of anticodon-engineered sup-tRNAs among isodecoders of 10 human tRNA families in HEK cells; sup-tRNA^{Arg} gene electroporated into mouse skeletalmuscle with luciferase reporter; co-transfection of sup-tRNA with PTC-CFTR genes in Xenopus oocytes,"Lueck, J. D. et al. Engineered transfer RNAs for suppression of premature termination codons. Nat. Commun. 10, 822 (2019)."
Model protein,,Nluc,Oplophorus gracilirostris,"Nluc(c.484G>T,c.486C>A)[ful length]","c.484G>T,c.486C>A","GGC, p.Gly162",UGA,IVT_tRNA,liposome,,Gly(GCC),Gly(UCA),URS0000631D89_9606,chr6.trna86,Homo sapiens,GCAUGGGUGAUUCAGUGGUAGAAUUUUCACCU(GCC)AUGCAGGAGGUCCAGGUUCAUUUCCUGGCCUAUGCA,GCAUGGGUGAUUCAGUGGUAGAAUUUUCACCU(UCA)AUGCAGGAGGUCCAGGUUCAUUUCCUGGCCUAUGCA,"Query  1 GCAUGGGUGAUUCAGUGGUAGAAUUUUCACCUUCAAUGCAGGAGGUCCAGGUUCAUUUCCUGGCCUAUGCA 71
|||||||||||||||||||||||||||||||| | ||||||||||||||||||||||||||||||||||||
Sbjct  1 GCAUGGGUGAUUCAGUGGUAGAAUUUUCACCUGCCAUGCAGGAGGUCCAGGUUCAUUUCCUGGCCUAUGCA 71",,,,,,NAN,0.941,absolute expression,,HEK293,low risk,not discussed,Screening of anticodon-engineered sup-tRNAs among isodecoders of 10 human tRNA families in HEK cells; sup-tRNA^{Arg} gene electroporated into mouse skeletalmuscle with luciferase reporter; co-transfection of sup-tRNA with PTC-CFTR genes in Xenopus oocytes,"Lueck, J. D. et al. Engineered transfer RNAs for suppression of premature termination codons. Nat. Commun. 10, 822 (2019)."
Model protein,,Nluc,Oplophorus gracilirostris,"Nluc(c.484G>T,c.486C>A)[ful length]","c.484G>T,c.486C>A","GGC, p.Gly162",UGA,IVT_tRNA,liposome,,Gly(UCC),Gly(UCA),URS00000AED6F_9606,chr19.trna2,Homo sapiens,GCGUUGGUGGUAUAGUGGUUAGCAUAGCUGCCU(UCC)AAGCAGUUGACCCGGGUUCGAUUCCCGGCCAACGCA,GCGUUGGUGGUAUAGUGGUUAGCAUAGCUGCCU(UCA)AAGCAGUUGACCCGGGUUCGAUUCCCGGCCAACGCA,"Query  1 GCGUUGGUGGUAUAGUGGUUAGCAUAGCUGCCUUCAAAGCAGUUGACCCGGGUUCGAUUCCCGGCCAACGCA 72
||||||||||||||||||||||||||||||||||| ||||||||||||||||||||||||||||||||||||
Sbjct  1 GCGUUGGUGGUAUAGUGGUUAGCAUAGCUGCCUUCCAAGCAGUUGACCCGGGUUCGAUUCCCGGCCAACGCA 72",,,,,,NAN,126.461,absolute expression,,HEK293,low risk,not discussed,Screening of anticodon-engineered sup-tRNAs among isodecoders of 10 human tRNA families in HEK cells; sup-tRNA^{Arg} gene electroporated into mouse skeletalmuscle with luciferase reporter; co-transfection of sup-tRNA with PTC-CFTR genes in Xenopus oocytes,"Lueck, J. D. et al. Engineered transfer RNAs for suppression of premature termination codons. Nat. Commun. 10, 822 (2019)."
Model protein,,Nluc,Oplophorus gracilirostris,"Nluc(c.484G>T,c.486C>A)[ful length]","c.484G>T,c.486C>A","GGC, p.Gly162",UGA,IVT_tRNA,liposome,,Gly(UCC),Gly(UCA),URS000034AAC2_9606,chr1.trna68,Homo sapiens,GCGUUGGUGGUAUAGUGGUGAGCAUAGCUGCCU(UCC)AAGCAGUUGACCCGGGUUCGAUUCCCGGCCAACGCA,GCGUUGGUGGUAUAGUGGUGAGCAUAGCUGCCU(UCA)AAGCAGUUGACCCGGGUUCGAUUCCCGGCCAACGCA,"Query  1 GCGUUGGUGGUAUAGUGGUGAGCAUAGCUGCCUUCAAAGCAGUUGACCCGGGUUCGAUUCCCGGCCAACGCA 72
||||||||||||||||||||||||||||||||||| ||||||||||||||||||||||||||||||||||||
Sbjct  1 GCGUUGGUGGUAUAGUGGUGAGCAUAGCUGCCUUCCAAGCAGUUGACCCGGGUUCGAUUCCCGGCCAACGCA 72",,,,,,NAN,100.328,absolute expression,,HEK293,low risk,not discussed,Screening of anticodon-engineered sup-tRNAs among isodecoders of 10 human tRNA families in HEK cells; sup-tRNA^{Arg} gene electroporated into mouse skeletalmuscle with luciferase reporter; co-transfection of sup-tRNA with PTC-CFTR genes in Xenopus oocytes,"Lueck, J. D. et al. Engineered transfer RNAs for suppression of premature termination codons. Nat. Commun. 10, 822 (2019)."
Model protein,,Nluc,Oplophorus gracilirostris,"Nluc(c.484G>T,c.486C>A)[ful length]","c.484G>T,c.486C>A","GGC, p.Gly162",UGA,IVT_tRNA,liposome,,Gly(UCC),Gly(UCA),URS0000716B70_9606,chr17.trna9,Homo sapiens,GCGUUGGUGGUAUAGUGGUAAGCAUAGCUGCCU(UCC)AAGCAGUUGACCCGGGUUCGAUUCCCGGCCAACGCA,GCGUUGGUGGUAUAGUGGUAAGCAUAGCUGCCU(UCA)AAGCAGUUGACCCGGGUUCGAUUCCCGGCCAACGCA,"Query  1 GCGUUGGUGGUAUAGUGGUAAGCAUAGCUGCCUUCAAAGCAGUUGACCCGGGUUCGAUUCCCGGCCAACGCA 72
||||||||||||||||||||||||||||||||||| ||||||||||||||||||||||||||||||||||||
Sbjct  1 GCGUUGGUGGUAUAGUGGUAAGCAUAGCUGCCUUCCAAGCAGUUGACCCGGGUUCGAUUCCCGGCCAACGCA 72",,,,,,NAN,65.453,absolute expression,,HEK293,low risk,not discussed,Screening of anticodon-engineered sup-tRNAs among isodecoders of 10 human tRNA families in HEK cells; sup-tRNA^{Arg} gene electroporated into mouse skeletalmuscle with luciferase reporter; co-transfection of sup-tRNA with PTC-CFTR genes in Xenopus oocytes,"Lueck, J. D. et al. Engineered transfer RNAs for suppression of premature termination codons. Nat. Commun. 10, 822 (2019)."
Model protein,,Nluc,Oplophorus gracilirostris,"Nluc(c.484G>T,c.486C>A)[ful length]","c.484G>T,c.486C>A","GGC, p.Gly162",UGA,IVT_tRNA,liposome,,Gly(UCC),Gly(UCA),URS000068668E_9606,chr1.trna93,Homo sapiens,GCGUUGGUGGUAUAGUGGUGAGCAUAGUUGCCU(UCC)AAGCAGUUGACCCGGGCUCGAUUCCCGCCCAACGCA,GCGUUGGUGGUAUAGUGGUGAGCAUAGUUGCCU(UCA)AAGCAGUUGACCCGGGCUCGAUUCCCGCCCAACGCA,"Query  1 GCGUUGGUGGUAUAGUGGUGAGCAUAGUUGCCUUCAAAGCAGUUGACCCGGGCUCGAUUCCCGCCCAACGCA 72
||||||||||||||||||||||||||||||||||| ||||||||||||||||||||||||||||||||||||
Sbjct  1 GCGUUGGUGGUAUAGUGGUGAGCAUAGUUGCCUUCCAAGCAGUUGACCCGGGCUCGAUUCCCGCCCAACGCA 72",,,,,,NAN,0.997,absolute expression,,HEK293,low risk,not discussed,Screening of anticodon-engineered sup-tRNAs among isodecoders of 10 human tRNA families in HEK cells; sup-tRNA^{Arg} gene electroporated into mouse skeletalmuscle with luciferase reporter; co-transfection of sup-tRNA with PTC-CFTR genes in Xenopus oocytes,"Lueck, J. D. et al. Engineered transfer RNAs for suppression of premature termination codons. Nat. Commun. 10, 822 (2019)."
Model protein,,Nluc,Oplophorus gracilirostris,"Nluc(c.484G>T,c.486C>A)[ful length]","c.484G>T,c.486C>A","GGC, p.Gly162",UGA,IVT_tRNA,liposome,,Gly(UCC),Gly(UCA),URS000068668E_9606,chr1.trna93,Homo sapiens,GCGUUGGUGGUAUAGUGGUGAGCAUAGUUGCCU(UCC)AAGCAGUUGACCCGGGCUCGAUUCCCGCCCAACGCA,GCGUUGGUGGUAUAGUGGUGAGCAUAGUUGCCU(UCA)AAGCAGUUGACCCGGGCUCGAUUCCCGGCCAACGCA,"Query  1 GCGUUGGUGGUAUAGUGGUGAGCAUAGUUGCCUUCAAAGCAGUUGACCCGGGCUCGAUUCCCGGCCAACGCA 72
||||||||||||||||||||||||||||||||||| ||||||||||||||||||||||||||| ||||||||
Sbjct  1 GCGUUGGUGGUAUAGUGGUGAGCAUAGUUGCCUUCCAAGCAGUUGACCCGGGCUCGAUUCCCGCCCAACGCA 72",,,,,,NAN,0.764,absolute expression,,HEK293,low risk,not discussed,Screening of anticodon-engineered sup-tRNAs among isodecoders of 10 human tRNA families in HEK cells; sup-tRNA^{Arg} gene electroporated into mouse skeletalmuscle with luciferase reporter; co-transfection of sup-tRNA with PTC-CFTR genes in Xenopus oocytes,"Lueck, J. D. et al. Engineered transfer RNAs for suppression of premature termination codons. Nat. Commun. 10, 822 (2019)."
Model protein,,Nluc,Oplophorus gracilirostris,"Nluc(c.484G>T,c.486C>A)[ful length]","c.484G>T,c.486C>A","GGC, p.Gly162",UGA,IVT_tRNA,liposome,,Arg(ACG),Arg(UCA),URS0000416E93_9606,chr6.trna6,Homo sapiens,GGGCCAGUGGCGCAAUGGAUAACGCGUCUGACU(ACG)GAUCAGAAGAUUCCAGGUUCGACUCCUGGCUGGCUCG,GGGCCAGUGGCGCAAUGGAUAACGCGUCUGACU(UCA)GAUCAGAAGAUUCCAGGUUCGACUCCUGGCUGGCUCG,"Query  2 GGCCAGUGGCGCAAUGGAUAACGCGUCUGACUUCAGAUCAGAAGAUUCCAGGUUCGACUCCUGGCUGGCUC 72
|||||||||||||||||||||||||||||||| | ||||||||||||||||||||||||||||||||||||
Sbjct  2 GGCCAGUGGCGCAAUGGAUAACGCGUCUGACUACGGAUCAGAAGAUUCCAGGUUCGACUCCUGGCUGGCUC 72",,,,,,NAN,3.155,absolute expression,,HEK293,induced approximately a 2-fold increase in 3′UTR ribosome density for the cognate stop codon,not discussed,Screening of anticodon-engineered sup-tRNAs among isodecoders of 10 human tRNA families in HEK cells; sup-tRNA^{Arg} gene electroporated into mouse skeletalmuscle with luciferase reporter; co-transfection of sup-tRNA with PTC-CFTR genes in Xenopus oocytes,"Lueck, J. D. et al. Engineered transfer RNAs for suppression of premature termination codons. Nat. Commun. 10, 822 (2019)."
Model protein,,Nluc,Oplophorus gracilirostris,"Nluc(c.484G>T,c.486C>A)[ful length]","c.484G>T,c.486C>A","GGC, p.Gly162",UGA,IVT_tRNA,liposome,,Arg(ACG),Arg(UCA),URS00002DDD59_9606,chr6.trna37,Homo sapiens,GGCCAGUGGCGCAAUGGAUAACGCGUCUGACU(ACG)GAUCAGAAGAUUCUAGGUUCGACUCCUGGCUGGCUC,GGGCCAGUGGCGCAAUGGAUAACGCGUCUGACU(UCA)GAUCAGAAGAUUCUAGGUUCGACUCCUGGCUGGCUCG,"Query  2 GGCCAGUGGCGCAAUGGAUAACGCGUCUGACUUCAGAUCAGAAGAUUCUAGGUUCGACUCCUGGCUGGCUC 72
|||||||||||||||||||||||||||||||| | ||||||||||||||||||||||||||||||||||||
Sbjct  2 GGCCAGUGGCGCAAUGGAUAACGCGUCUGACUACGGAUCAGAAGAUUCUAGGUUCGACUCCUGGCUGGCUC 72",,,,,,NAN,159.567,absolute expression,,HEK293,induced approximately a 2-fold increase in 3′UTR ribosome density for the cognate stop codon,not discussed,Screening of anticodon-engineered sup-tRNAs among isodecoders of 10 human tRNA families in HEK cells; sup-tRNA^{Arg} gene electroporated into mouse skeletalmuscle with luciferase reporter; co-transfection of sup-tRNA with PTC-CFTR genes in Xenopus oocytes,"Lueck, J. D. et al. Engineered transfer RNAs for suppression of premature termination codons. Nat. Commun. 10, 822 (2019)."
Model protein,,Nluc,Oplophorus gracilirostris,"Nluc(c.484G>T,c.486C>A)[ful length]","c.484G>T,c.486C>A","GGC, p.Gly162",UGA,IVT_tRNA,liposome,,Arg(CCG),Arg(UCA),URS00001D909A_9606,chr16.trna2,Homo sapiens,GCCGCGUGGCCUAAUGGAUAAGGCGUCUGAUU(CCG)GAUCAGAAGAUUGAGGGUUCGAGUCCCUUCGUGGUC,GGCCGCGUGGCCUAAUGGAUAAGGCGUCUGAUU(UCA)GAUCAGAAGAUUGAGGGUUCGAGUCCCUUCGUGGUCG,"Query  2 GCCGCGUGGCCUAAUGGAUAAGGCGUCUGAUUUCAGAUCAGAAGAUUGAGGGUUCGAGUCCCUUCGUGGUC 72
|||||||||||||||||||||||||||||||| | ||||||||||||||||||||||||||||||||||||
Sbjct  2 GCCGCGUGGCCUAAUGGAUAAGGCGUCUGAUUCCGGAUCAGAAGAUUGAGGGUUCGAGUCCCUUCGUGGUC 72",,,,,,NAN,23.687,absolute expression,,HEK293,induced approximately a 2-fold increase in 3′UTR ribosome density for the cognate stop codon,not discussed,Screening of anticodon-engineered sup-tRNAs among isodecoders of 10 human tRNA families in HEK cells; sup-tRNA^{Arg} gene electroporated into mouse skeletalmuscle with luciferase reporter; co-transfection of sup-tRNA with PTC-CFTR genes in Xenopus oocytes,"Lueck, J. D. et al. Engineered transfer RNAs for suppression of premature termination codons. Nat. Commun. 10, 822 (2019)."
Model protein,,Nluc,Oplophorus gracilirostris,"Nluc(c.484G>T,c.486C>A)[ful length]","c.484G>T,c.486C>A","GGC, p.Gly162",UGA,IVT_tRNA,liposome,,Arg(CCG),Arg(UCA),URS000059900F_9606,chr17.trna21,Homo sapiens,GACCCAGUGGCCUAAUGGAUAAGGCAUCAGCCU(CCG)GAGCUGGGGAUUGUGGGUUCGAGUCCCAUCUGGGUC,GACCCAGUGGCCUAAUGGAUAAGGCAUCAGCCU(UCA)GAGCUGGGGAUUGUGGGUUCGAGUCCCAUCUGGGUCG,"Query  1 GACCCAGUGGCCUAAUGGAUAAGGCAUCAGCCUUCAGAGCUGGGGAUUGUGGGUUCGAGUCCCAUCUGGGUC 72
||||||||||||||||||||||||||||||||| | ||||||||||||||||||||||||||||||||||||
Sbjct  1 GACCCAGUGGCCUAAUGGAUAAGGCAUCAGCCUCCGGAGCUGGGGAUUGUGGGUUCGAGUCCCAUCUGGGUC 72",,,,,,NAN,180.131,absolute expression,,HEK293,induced approximately a 2-fold increase in 3′UTR ribosome density for the cognate stop codon,not discussed,Screening of anticodon-engineered sup-tRNAs among isodecoders of 10 human tRNA families in HEK cells; sup-tRNA^{Arg} gene electroporated into mouse skeletalmuscle with luciferase reporter; co-transfection of sup-tRNA with PTC-CFTR genes in Xenopus oocytes,"Lueck, J. D. et al. Engineered transfer RNAs for suppression of premature termination codons. Nat. Commun. 10, 822 (2019)."
Model protein,,Nluc,Oplophorus gracilirostris,"Nluc(c.484G>T,c.486C>A)[ful length]","c.484G>T,c.486C>A","GGC, p.Gly162",UGA,IVT_tRNA,liposome,,Arg(CCU),Arg(UCA),URS00002D7BB5_9606,chr17.trna16,Homo sapiens,CCCCAGUGGCCUAAUGGAUAAGGCACUGGCCU(CCU)AAGCCAGGGAUUGUGGGUUCGAGUCCCACCUGGGGUA,GCCCCAGUGGCCUAAUGGAUAAGGCACUGGCCU(UCA)AAGCCAGGGAUUGUGGGUUCGAGUCCCACCUGGGGUA,"Query  2 CCCCAGUGGCCUAAUGGAUAAGGCACUGGCCUUCAAAGCCAGGGAUUGUGGGUUCGAGUCCCACCUGGGGUA 73
|||||||||||||||||||||||||||||||| | |||||||||||||||||||||||||||||||||||||
Sbjct  2 CCCCAGUGGCCUAAUGGAUAAGGCACUGGCCUCCUAAGCCAGGGAUUGUGGGUUCGAGUCCCACCUGGGGUA 73",,,,,,NAN,196.627,absolute expression,,HEK293,induced approximately a 2-fold increase in 3′UTR ribosome density for the cognate stop codon,not discussed,Screening of anticodon-engineered sup-tRNAs among isodecoders of 10 human tRNA families in HEK cells; sup-tRNA^{Arg} gene electroporated into mouse skeletalmuscle with luciferase reporter; co-transfection of sup-tRNA with PTC-CFTR genes in Xenopus oocytes,"Lueck, J. D. et al. Engineered transfer RNAs for suppression of premature termination codons. Nat. Commun. 10, 822 (2019)."
Model protein,,Nluc,Oplophorus gracilirostris,"Nluc(c.484G>T,c.486C>A)[ful length]","c.484G>T,c.486C>A","GGC, p.Gly162",UGA,IVT_tRNA,liposome,,Arg(CCU),Arg(UCA),URS0000390F3A_9606,chr17.trna19,Homo sapiens,CCCCAGUGGCCUAAUGGAUAAGGCACUGGCCU(CCU)AAGCCAGGGAUUGUGGGUUCGAGUCCCACCUGGGGU,GCCCCAGUGGCCUAAUGGAUAAGGCACUGGCCU(UCA)AAGCCAGGGAUUGUGGGUUCGAGUCCCACCUGGGGUG,"Query  2 CCCCAGUGGCCUAAUGGAUAAGGCACUGGCCUUCAAAGCCAGGGAUUGUGGGUUCGAGUCCCACCUGGGGU 72
|||||||||||||||||||||||||||||||| | ||||||||||||||||||||||||||||||||||||
Sbjct  2 CCCCAGUGGCCUAAUGGAUAAGGCACUGGCCUCCUAAGCCAGGGAUUGUGGGUUCGAGUCCCACCUGGGGU 72",,,,,,NAN,267.463,absolute expression,,HEK293,induced approximately a 2-fold increase in 3′UTR ribosome density for the cognate stop codon,not discussed,Screening of anticodon-engineered sup-tRNAs among isodecoders of 10 human tRNA families in HEK cells; sup-tRNA^{Arg} gene electroporated into mouse skeletalmuscle with luciferase reporter; co-transfection of sup-tRNA with PTC-CFTR genes in Xenopus oocytes,"Lueck, J. D. et al. Engineered transfer RNAs for suppression of premature termination codons. Nat. Commun. 10, 822 (2019)."
Model protein,,Nluc,Oplophorus gracilirostris,"Nluc(c.484G>T,c.486C>A)[ful length]","c.484G>T,c.486C>A","GGC, p.Gly162",UGA,IVT_tRNA,liposome,,Arg(CCU),Arg(UCA),URS000005A7A9_9606,chr16.trna3,Homo sapiens,CCCCGGUGGCCUAAUGGAUAAGGCAUUGGCCU(CCU)AAGCCAGGGAUUGUGGGUUCGAGUCCCACCCGGGGUA,GCCCCGGUGGCCUAAUGGAUAAGGCAUUGGCCU(UCA)AAGCCAGGGAUUGUGGGUUCGAGUCCCACCCGGGGUA,"Query  2 CCCCGGUGGCCUAAUGGAUAAGGCAUUGGCCUUCAAAGCCAGGGAUUGUGGGUUCGAGUCCCACCCGGGGUA 73
|||||||||||||||||||||||||||||||| | |||||||||||||||||||||||||||||||||||||
Sbjct  2 CCCCGGUGGCCUAAUGGAUAAGGCAUUGGCCUCCUAAGCCAGGGAUUGUGGGUUCGAGUCCCACCCGGGGUA 73",,,,,,NAN,245.46,absolute expression,,HEK293,induced approximately a 2-fold increase in 3′UTR ribosome density for the cognate stop codon,not discussed,Screening of anticodon-engineered sup-tRNAs among isodecoders of 10 human tRNA families in HEK cells; sup-tRNA^{Arg} gene electroporated into mouse skeletalmuscle with luciferase reporter; co-transfection of sup-tRNA with PTC-CFTR genes in Xenopus oocytes,"Lueck, J. D. et al. Engineered transfer RNAs for suppression of premature termination codons. Nat. Commun. 10, 822 (2019)."
Model protein,,Nluc,Oplophorus gracilirostris,"Nluc(c.484G>T,c.486C>A)[ful length]","c.484G>T,c.486C>A","GGC, p.Gly162",UGA,IVT_tRNA,liposome,,Arg(CCU),Arg(UCA),URS00003A4B65_9606,chr7.trna5,Homo sapiens,GCCCCAGUGGCCUAAUGGAUAAGGCAUUGGCCU(CCU)AAGCCAGGGAUUGUGGGUUCGAGUCCCAUCUGGGGU,GCCCCAGUGGCCUAAUGGAUAAGGCAUUGGCCU(UCA)AAGCCAGGGAUUGUGGGUUCGAGUCCCAUCUGGGGUG,"Query  1 GCCCCAGUGGCCUAAUGGAUAAGGCAUUGGCCUUCAAAGCCAGGGAUUGUGGGUUCGAGUCCCAUCUGGGGU 72
||||||||||||||||||||||||||||||||| | ||||||||||||||||||||||||||||||||||||
Sbjct  1 GCCCCAGUGGCCUAAUGGAUAAGGCAUUGGCCUCCUAAGCCAGGGAUUGUGGGUUCGAGUCCCAUCUGGGGU 72",,,,,,NAN,232.561,absolute expression,,HEK293,induced approximately a 2-fold increase in 3′UTR ribosome density for the cognate stop codon,not discussed,Screening of anticodon-engineered sup-tRNAs among isodecoders of 10 human tRNA families in HEK cells; sup-tRNA^{Arg} gene electroporated into mouse skeletalmuscle with luciferase reporter; co-transfection of sup-tRNA with PTC-CFTR genes in Xenopus oocytes,"Lueck, J. D. et al. Engineered transfer RNAs for suppression of premature termination codons. Nat. Commun. 10, 822 (2019)."
Model protein,,Nluc,Oplophorus gracilirostris,"Nluc(c.484G>T,c.486C>A)[ful length]","c.484G>T,c.486C>A","GGC, p.Gly162",UGA,IVT_tRNA,liposome,,Arg(CCU),Arg(UCA),URS0000690130_9606,chr16.trna13,Homo sapiens,GCCCCAGUGGCCUGAUGGAUAAGGUACUGGCCU(CCU)AAGCCAGGGAUUGUGGGUUCGAGUUCCACCUGGGGUA,GCCCCAGUGGCCUGAUGGAUAAGGUACUGGCCU(UCA)AAGCCAGGGAUUGUGGGUUCGAGUUCCACCUGGGGUA,"Query  1 GCCCCAGUGGCCUGAUGGAUAAGGUACUGGCCUUCAAAGCCAGGGAUUGUGGGUUCGAGUUCCACCUGGGGUA 73
||||||||||||||||||||||||||||||||| | |||||||||||||||||||||||||||||||||||||
Sbjct  1 GCCCCAGUGGCCUGAUGGAUAAGGUACUGGCCUCCUAAGCCAGGGAUUGUGGGUUCGAGUUCCACCUGGGGUA 73",,,,,,NAN,9.906,absolute expression,,HEK293,induced approximately a 2-fold increase in 3′UTR ribosome density for the cognate stop codon,not discussed,Screening of anticodon-engineered sup-tRNAs among isodecoders of 10 human tRNA families in HEK cells; sup-tRNA^{Arg} gene electroporated into mouse skeletalmuscle with luciferase reporter; co-transfection of sup-tRNA with PTC-CFTR genes in Xenopus oocytes,"Lueck, J. D. et al. Engineered transfer RNAs for suppression of premature termination codons. Nat. Commun. 10, 822 (2019)."
Model protein,,Nluc,Oplophorus gracilirostris,"Nluc(c.484G>T,c.486C>A)[ful length]","c.484G>T,c.486C>A","GGC, p.Gly162",UGA,IVT_tRNA,liposome,,Arg(UCG),Arg(UCA),URS00000CC06A_9606,chr15.trna4,Homo sapiens,GCCGCGUGGCCUAAUGGAUAAGGCGUCUGACU(UCG)GAUCAGAAGAUUGCAGGUUCGAGUCCUGCCGCGGUC,GGCCGCGUGGCCUAAUGGAUAAGGCGUCUGACU(UCA)GAUCAGAAGAUUGCAGGUUCGAGUCCUGCCGCGGUCG,"Query  2 GCCGCGUGGCCUAAUGGAUAAGGCGUCUGACUUCAGAUCAGAAGAUUGCAGGUUCGAGUCCUGCCGCGGUC 72
|||||||||||||||||||||||||||||||||| ||||||||||||||||||||||||||||||||||||
Sbjct  2 GCCGCGUGGCCUAAUGGAUAAGGCGUCUGACUUCGGAUCAGAAGAUUGCAGGUUCGAGUCCUGCCGCGGUC 72",,,,,,NAN,152.921,absolute expression,,HEK293,induced approximately a 2-fold increase in 3′UTR ribosome density for the cognate stop codon,not discussed,Screening of anticodon-engineered sup-tRNAs among isodecoders of 10 human tRNA families in HEK cells; sup-tRNA^{Arg} gene electroporated into mouse skeletalmuscle with luciferase reporter; co-transfection of sup-tRNA with PTC-CFTR genes in Xenopus oocytes,"Lueck, J. D. et al. Engineered transfer RNAs for suppression of premature termination codons. Nat. Commun. 10, 822 (2019)."
Model protein,,Nluc,Oplophorus gracilirostris,"Nluc(c.484G>T,c.486C>A)[ful length]","c.484G>T,c.486C>A","GGC, p.Gly162",UGA,IVT_tRNA,liposome,,Arg(UCG),Arg(UCA),URS00006D69C0_9606,chr6.trna4,Homo sapiens,GACCACGUGGCCUAAUGGAUAAGGCGUCUGACU(UCG)GAUCAGAAGAUUGAGGGUUCGAAUCCCUCCGUGGUUA,GACCACGUGGCCUAAUGGAUAAGGCGUCUGACU(UCA)GAUCAGAAGAUUGAGGGUUCGAAUCCCUCCGUGGUUA,"Query  1 GACCACGUGGCCUAAUGGAUAAGGCGUCUGACUUCAGAUCAGAAGAUUGAGGGUUCGAAUCCCUCCGUGGUUA 73
||||||||||||||||||||||||||||||||||| |||||||||||||||||||||||||||||||||||||
Sbjct  1 GACCACGUGGCCUAAUGGAUAAGGCGUCUGACUUCGGAUCAGAAGAUUGAGGGUUCGAAUCCCUCCGUGGUUA 73",,,,,,NAN,169.813,absolute expression,,HEK293,induced approximately a 2-fold increase in 3′UTR ribosome density for the cognate stop codon,not discussed,Screening of anticodon-engineered sup-tRNAs among isodecoders of 10 human tRNA families in HEK cells; sup-tRNA^{Arg} gene electroporated into mouse skeletalmuscle with luciferase reporter; co-transfection of sup-tRNA with PTC-CFTR genes in Xenopus oocytes,"Lueck, J. D. et al. Engineered transfer RNAs for suppression of premature termination codons. Nat. Commun. 10, 822 (2019)."
Model protein,,Nluc,Oplophorus gracilirostris,"Nluc(c.484G>T,c.486C>A)[ful length]","c.484G>T,c.486C>A","GGC, p.Gly162",UGA,IVT_tRNA,liposome,,Arg(UCG),Arg(UCA),URS000066103F_9606,chr17.trna17,Homo sapiens,GACCGCGUGGCCUAAUGGAUAAGGCGUCUGACU(UCG)GAUCAGAAGAUUGAGGGUUCGAGUCCCUUCGUGGUC,GACCGCGUGGCCUAAUGGAUAAGGCGUCUGACU(UCA)GAUCAGAAGAUUGAGGGUUCGAGUCCCUUCGUGGUCG,"Query  1 GACCGCGUGGCCUAAUGGAUAAGGCGUCUGACUUCAGAUCAGAAGAUUGAGGGUUCGAGUCCCUUCGUGGUC 72
||||||||||||||||||||||||||||||||||| ||||||||||||||||||||||||||||||||||||
Sbjct  1 GACCGCGUGGCCUAAUGGAUAAGGCGUCUGACUUCGGAUCAGAAGAUUGAGGGUUCGAGUCCCUUCGUGGUC 72",,,,,,NAN,215.598,absolute expression,,HEK293,induced approximately a 2-fold increase in 3′UTR ribosome density for the cognate stop codon,not discussed,Screening of anticodon-engineered sup-tRNAs among isodecoders of 10 human tRNA families in HEK cells; sup-tRNA^{Arg} gene electroporated into mouse skeletalmuscle with luciferase reporter; co-transfection of sup-tRNA with PTC-CFTR genes in Xenopus oocytes,"Lueck, J. D. et al. Engineered transfer RNAs for suppression of premature termination codons. Nat. Commun. 10, 822 (2019)."
Model protein,,Nluc,Oplophorus gracilirostris,"Nluc(c.484G>T,c.486C>A)[ful length]","c.484G>T,c.486C>A","GGC, p.Gly162",UGA,IVT_tRNA,liposome,,Arg(UCG),Arg(UCA),URS0000677EA0_9606,chr6.trna3,Homo sapiens,GACCACGUGGCCUAAUGGAUAAGGCGUCUGACU(UCG)GAUCAGAAGAUUGAGGGUUCGAAUCCCUUCGUGGUUA,GACCACGUGGCCUAAUGGAUAAGGCGUCUGACU(UCA)GAUCAGAAGAUUGAGGGUUCGAAUCCCUUCGUGGUUA,"Query  1 GACCACGUGGCCUAAUGGAUAAGGCGUCUGACUUCAGAUCAGAAGAUUGAGGGUUCGAAUCCCUUCGUGGUUA 73
||||||||||||||||||||||||||||||||||| |||||||||||||||||||||||||||||||||||||
Sbjct  1 GACCACGUGGCCUAAUGGAUAAGGCGUCUGACUUCGGAUCAGAAGAUUGAGGGUUCGAAUCCCUUCGUGGUUA 73",,,,,,NAN,181.705,absolute expression,,HEK293,induced approximately a 2-fold increase in 3′UTR ribosome density for the cognate stop codon,not discussed,Screening of anticodon-engineered sup-tRNAs among isodecoders of 10 human tRNA families in HEK cells; sup-tRNA^{Arg} gene electroporated into mouse skeletalmuscle with luciferase reporter; co-transfection of sup-tRNA with PTC-CFTR genes in Xenopus oocytes,"Lueck, J. D. et al. Engineered transfer RNAs for suppression of premature termination codons. Nat. Commun. 10, 822 (2019)."
primary ciliary dyskinesia (PCD),RSPH4A,fusion protein,Homo sapiens,"ATG+RSPH4A(c.1468C>T)[1447,1491]+Fluc",c.1468C>T,"CGA, p.Arg490",UGA,IVT_tRNA,liposome,,Ser(AGA),Ser(UCA),,chr6.tRNA151,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(AGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGGCAGGCU(UCA)AACCUGUUGGGGUUUCCCCGCACGGGUUCGAAUCCCGUCGACUACGCCA,,,,,,,NAN,7.25%,rescued rate (protein),,CFRE41o-,not discussed,not discussed,"Investigating the impact of translation rate on readthrough efficiency, by altering the PTC upstream sequence","Bharti, N., Santos, L., Davyt, M. et al. Translation velocity determines the efficacy of engineered suppressor tRNAs on pathogenic nonsense mutations. Nat Commun 15, 2957 (2024). https://doi.org/10.1038/s41467-024-47258-9"
primary ciliary dyskinesia (PCD),DNAH5,fusion protein,Homo sapiens,"ATG+DNAH5(c.5131C>T)[5110,5154]+Fluc",c.5131C>T,"CGA, p.Arg1711",UGA,IVT_tRNA,liposome,,Ser(AGA),Ser(UCA),,chr6.tRNA151,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(AGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGGCAGGCU(UCA)AACCUGUUGGGGUUUCCCCGCACGGGUUCGAAUCCCGUCGACUACGCCA,,,,,,,NAN,7.86%,rescued rate (protein),,CFRE41o-,not discussed,not discussed,"Investigating the impact of translation rate on readthrough efficiency, by altering the PTC upstream sequence","Bharti, N., Santos, L., Davyt, M. et al. Translation velocity determines the efficacy of engineered suppressor tRNAs on pathogenic nonsense mutations. Nat Commun 15, 2957 (2024). https://doi.org/10.1038/s41467-024-47258-10"
primary ciliary dyskinesia (PCD),DNAH5,fusion protein,Homo sapiens,"ATG+DNAH5(c.8029C>T)[8008,8052]+Fluc",c.8029C>T,"CGA, p.Arg2677",UGA,IVT_tRNA,liposome,,Ser(AGA),Ser(UCA),,chr6.tRNA151,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(AGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGGCAGGCU(UCA)AACCUGUUGGGGUUUCCCCGCACGGGUUCGAAUCCCGUCGACUACGCCA,,,,,,,NAN,11.71%,rescued rate (protein),,CFRE41o-,not discussed,not discussed,"Investigating the impact of translation rate on readthrough efficiency, by altering the PTC upstream sequence","Bharti, N., Santos, L., Davyt, M. et al. Translation velocity determines the efficacy of engineered suppressor tRNAs on pathogenic nonsense mutations. Nat Commun 15, 2957 (2024). https://doi.org/10.1038/s41467-024-47258-11"
primary ciliary dyskinesia (PCD),DNAH5,fusion protein,Homo sapiens,"ATG+DNAH5(c.5647C>T)[5626,5670]+Fluc",c.5647C>T,"CGA, p.Arg1883",UGA,IVT_tRNA,liposome,,Ser(AGA),Ser(UCA),,chr6.tRNA151,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(AGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGGCAGGCU(UCA)AACCUGUUGGGGUUUCCCCGCACGGGUUCGAAUCCCGUCGACUACGCCA,,,,,,,NAN,3.78%,rescued rate (protein),,CFRE41o-,not discussed,not discussed,"Investigating the impact of translation rate on readthrough efficiency, by altering the PTC upstream sequence","Bharti, N., Santos, L., Davyt, M. et al. Translation velocity determines the efficacy of engineered suppressor tRNAs on pathogenic nonsense mutations. Nat Commun 15, 2957 (2024). https://doi.org/10.1038/s41467-024-47258-12"
cystic fibrosis,CFTR,fusion protein,Homo sapiens,"ATG+CFTR(c.3846G>A)[3823,3867]+Fluc",c.3846G>A,"UGG, p.Trp1282",UGA,IVT_tRNA,liposome,,Ser(AGA),Ser(UCA),,chr6.tRNA151,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(AGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGGCAGGCU(UCA)AACCUGUUGGGGUUUCCCCGCACGGGUUCGAAUCCCGUCGACUACGCCA,,,,,,,NAN,54.79%,rescued rate (protein),,CFRE41o-,not discussed,not discussed,"Investigating the impact of translation rate on readthrough efficiency, by altering the PTC upstream sequence","Bharti, N., Santos, L., Davyt, M. et al. Translation velocity determines the efficacy of engineered suppressor tRNAs on pathogenic nonsense mutations. Nat Commun 15, 2957 (2024). https://doi.org/10.1038/s41467-024-47258-13"
cystic fibrosis,CFTR,fusion protein,Homo sapiens,"ATG+CFTR(c.1657C>T)[1636,1680]+Fluc",c.1657C>T,"CGA, p.Arg553",UGA,IVT_tRNA,liposome,,Ser(AGA),Ser(UCA),,chr6.tRNA151,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(AGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGGCAGGCU(UCA)AACCUGUUGGGGUUUCCCCGCACGGGUUCGAAUCCCGUCGACUACGCCA,,,,,,,NAN,19.43%,rescued rate (protein),,CFRE41o-,not discussed,not discussed,"Investigating the impact of translation rate on readthrough efficiency, by altering the PTC upstream sequence","Bharti, N., Santos, L., Davyt, M. et al. Translation velocity determines the efficacy of engineered suppressor tRNAs on pathogenic nonsense mutations. Nat Commun 15, 2957 (2024). https://doi.org/10.1038/s41467-024-47258-14"
cystic fibrosis,CFTR,fusion protein,Homo sapiens,"ATG+CFTR(c.1624G>T)[1603,1647]+Fluc",c.1624G>T,"GGA, p.Gly542",UGA,IVT_tRNA,liposome,,Ser(AGA),Ser(UCA),,chr6.tRNA151,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(AGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGGCAGGCU(UCA)AACCUGUUGGGGUUUCCCCGCACGGGUUCGAAUCCCGUCGACUACGCCA,,,,,,,NAN,17.29%,rescued rate (protein),,CFRE41o-,not discussed,not discussed,"Investigating the impact of translation rate on readthrough efficiency, by altering the PTC upstream sequence","Bharti, N., Santos, L., Davyt, M. et al. Translation velocity determines the efficacy of engineered suppressor tRNAs on pathogenic nonsense mutations. Nat Commun 15, 2957 (2024). https://doi.org/10.1038/s41467-024-47258-15"
cystic fibrosis,CFTR,fusion protein,Homo sapiens,"ATG+CFTR(c.3612G>A)[3589,3633]+Fluc",c.3612G>A,"UGG, p.Trp1204",UGA,IVT_tRNA,liposome,,Ser(AGA),Ser(UCA),,chr6.tRNA151,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(AGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGGCAGGCU(UCA)AACCUGUUGGGGUUUCCCCGCACGGGUUCGAAUCCCGUCGACUACGCCA,,,,,,,NAN,15.74%,rescued rate (protein),,CFRE41o-,not discussed,not discussed,"Investigating the impact of translation rate on readthrough efficiency, by altering the PTC upstream sequence","Bharti, N., Santos, L., Davyt, M. et al. Translation velocity determines the efficacy of engineered suppressor tRNAs on pathogenic nonsense mutations. Nat Commun 15, 2957 (2024). https://doi.org/10.1038/s41467-024-47258-16"
cystic fibrosis,CFTR,fusion protein,Homo sapiens,"ATG+CFTR(c.2538G>A)[2515,2559]+Fluc",c.2538G>A,"UGG, p.Trp846",UGA,IVT_tRNA,liposome,,Ser(AGA),Ser(UCA),,chr6.tRNA151,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(AGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGGCAGGCU(UCA)AACCUGUUGGGGUUUCCCCGCACGGGUUCGAAUCCCGUCGACUACGCCA,,,,,,,NAN,3.99%,rescued rate (protein),,CFRE41o-,not discussed,not discussed,"Investigating the impact of translation rate on readthrough efficiency, by altering the PTC upstream sequence","Bharti, N., Santos, L., Davyt, M. et al. Translation velocity determines the efficacy of engineered suppressor tRNAs on pathogenic nonsense mutations. Nat Commun 15, 2957 (2024). https://doi.org/10.1038/s41467-024-47258-17"
cystic fibrosis,CFTR,fusion protein,Homo sapiens,"ATG+CFTR(c.1397C>G)[1375,1419]+Fluc",c.1397C>G,"UCA, p.Ser466",UGA,IVT_tRNA,liposome,,Ser(AGA),Ser(UCA),,chr6.tRNA151,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(AGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGGCAGGCU(UCA)AACCUGUUGGGGUUUCCCCGCACGGGUUCGAAUCCCGUCGACUACGCCA,,,,,,,NAN,21.71%,rescued rate (protein),,CFRE41o-,not discussed,not discussed,"Investigating the impact of translation rate on readthrough efficiency, by altering the PTC upstream sequence","Bharti, N., Santos, L., Davyt, M. et al. Translation velocity determines the efficacy of engineered suppressor tRNAs on pathogenic nonsense mutations. Nat Commun 15, 2957 (2024). https://doi.org/10.1038/s41467-024-47258-18"
cystic fibrosis,CFTR,fusion protein,Homo sapiens,"ATG+CFTR(c.3484C>T)[3449,3521]+Fluc",c.3484C>T,"CGA, p.Arg1162",UGA,IVT_tRNA,liposome,,Ser(AGA),Ser(UCA),,chr6.tRNA151,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(AGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGGCAGGCU(UCA)AACCUGUUGGGGUUUCCCCGCACGGGUUCGAAUCCCGUCGACUACGCCA,,,,,,,NAN,26.79%,rescued rate (protein),,CFRE41o-,not discussed,not discussed,"Investigating the impact of translation rate on readthrough efficiency, by altering the PTC upstream sequence","Bharti, N., Santos, L., Davyt, M. et al. Translation velocity determines the efficacy of engineered suppressor tRNAs on pathogenic nonsense mutations. Nat Commun 15, 2957 (2024). https://doi.org/10.1038/s41467-024-47258-19"
cystic fibrosis,CFTR,fusion protein,Homo sapiens,"ATG+CFTR(c.1572C>A)[1549,1593]+Fluc",c.1572C>A,"UGC, p.Cys524",UGA,IVT_tRNA,liposome,,Ser(AGA),Ser(UCA),,chr6.tRNA151,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(AGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGGCAGGCU(UCA)AACCUGUUGGGGUUUCCCCGCACGGGUUCGAAUCCCGUCGACUACGCCA,,,,,,,NAN,11.92%,rescued rate (protein),,CFRE41o-,not discussed,not discussed,"Investigating the impact of translation rate on readthrough efficiency, by altering the PTC upstream sequence","Bharti, N., Santos, L., Davyt, M. et al. Translation velocity determines the efficacy of engineered suppressor tRNAs on pathogenic nonsense mutations. Nat Commun 15, 2957 (2024). https://doi.org/10.1038/s41467-024-47258-20"
cystic fibrosis,CFTR,fusion protein,Homo sapiens,"ATG+CFTR(c.3611G>A)[3589,3633]+Fluc",c.3611G>A,"UGG, p.Trp1204",UAG,IVT_tRNA,liposome,,Ser(AGA),Ser(CUA),,chr6.tRNA151,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(AGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGGCAGGCU(CUA)AACCUGUUGGGGUUUCCCCGCACGGGUUCGAAUCCCGUCGACUACGCCA,,,,,,,NAN,4.12%,rescued rate (protein),,CFRE41o-,not discussed,not discussed,"Investigating the impact of translation rate on readthrough efficiency, by altering the PTC upstream sequence","Bharti, N., Santos, L., Davyt, M. et al. Translation velocity determines the efficacy of engineered suppressor tRNAs on pathogenic nonsense mutations. Nat Commun 15, 2957 (2024). https://doi.org/10.1038/s41467-024-47258-21"
cystic fibrosis,CFTR,fusion protein,Homo sapiens,"ATG+CFTR(c.2537G>A)[2515,2559]+Fluc",c.2537G>A,"UGG, p.Trp846",UAG,IVT_tRNA,liposome,,Ser(AGA),Ser(CUA),,chr6.tRNA151,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(AGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGGCAGGCU(CUA)AACCUGUUGGGGUUUCCCCGCACGGGUUCGAAUCCCGUCGACUACGCCA,,,,,,,NAN,-0.20%,rescued rate (protein),,CFRE41o-,not discussed,not discussed,"Investigating the impact of translation rate on readthrough efficiency, by altering the PTC upstream sequence","Bharti, N., Santos, L., Davyt, M. et al. Translation velocity determines the efficacy of engineered suppressor tRNAs on pathogenic nonsense mutations. Nat Commun 15, 2957 (2024). https://doi.org/10.1038/s41467-024-47258-22"
cystic fibrosis,CFTR,fusion protein,Homo sapiens,"ATG+CFTR(c.1397C>A,c.1398A>G)[1375,1419]+Fluc","c.1397C>A,c.1398A>G","UCA, p.Ser466",UAG,IVT_tRNA,liposome,,Ser(AGA),Ser(CUA),,chr6.tRNA151,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(AGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGGCAGGCU(CUA)AACCUGUUGGGGUUUCCCCGCACGGGUUCGAAUCCCGUCGACUACGCCA,,,,,,,NAN,21.61%,rescued rate (protein),,CFRE41o-,not discussed,not discussed,"Investigating the impact of translation rate on readthrough efficiency, by altering the PTC upstream sequence","Bharti, N., Santos, L., Davyt, M. et al. Translation velocity determines the efficacy of engineered suppressor tRNAs on pathogenic nonsense mutations. Nat Commun 15, 2957 (2024). https://doi.org/10.1038/s41467-024-47258-23"
cystic fibrosis,CFTR,fusion protein,Homo sapiens,"ATG+CFTR(c.1477C>T)[1456,1500]+Fluc",c.1477C>T,"CAG, p.Gln493",UAG,IVT_tRNA,liposome,,Ser(AGA),Ser(CUA),,chr6.tRNA151,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(AGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGGCAGGCU(CUA)AACCUGUUGGGGUUUCCCCGCACGGGUUCGAAUCCCGUCGACUACGCCA,,,,,,,NAN,2.99%,rescued rate (protein),,CFRE41o-,not discussed,not discussed,"Investigating the impact of translation rate on readthrough efficiency, by altering the PTC upstream sequence","Bharti, N., Santos, L., Davyt, M. et al. Translation velocity determines the efficacy of engineered suppressor tRNAs on pathogenic nonsense mutations. Nat Commun 15, 2957 (2024). https://doi.org/10.1038/s41467-024-47258-24"
cystic fibrosis,CFTR,fusion protein,Homo sapiens,"ATG+CFTR(c.2437G>T)[2416,2460]+Fluc",c.2437G>T,"GAG, p.Glu813",UAG,IVT_tRNA,liposome,,Ser(AGA),Ser(CUA),,chr6.tRNA151,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(AGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGGCAGGCU(CUA)AACCUGUUGGGGUUUCCCCGCACGGGUUCGAAUCCCGUCGACUACGCCA,,,,,,,NAN,1.41%,rescued rate (protein),,CFRE41o-,not discussed,not discussed,"Investigating the impact of translation rate on readthrough efficiency, by altering the PTC upstream sequence","Bharti, N., Santos, L., Davyt, M. et al. Translation velocity determines the efficacy of engineered suppressor tRNAs on pathogenic nonsense mutations. Nat Commun 15, 2957 (2024). https://doi.org/10.1038/s41467-024-47258-25"
cystic fibrosis,CFTR,fusion protein,Homo sapiens,"ATG+CFTR(c.170G>A)[148,192]+Fluc",c.170G>A,"UGG, p.Trp57",UAG,IVT_tRNA,liposome,,Ser(AGA),Ser(CUA),,chr6.tRNA151,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(AGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGGCAGGCU(CUA)AACCUGUUGGGGUUUCCCCGCACGGGUUCGAAUCCCGUCGACUACGCCA,,,,,,,NAN,19.93%,rescued rate (protein),,CFRE41o-,not discussed,not discussed,"Investigating the impact of translation rate on readthrough efficiency, by altering the PTC upstream sequence","Bharti, N., Santos, L., Davyt, M. et al. Translation velocity determines the efficacy of engineered suppressor tRNAs on pathogenic nonsense mutations. Nat Commun 15, 2957 (2024). https://doi.org/10.1038/s41467-024-47258-26"
cystic fibrosis,CFTR,fusion protein,Homo sapiens,"ATG+CFTR(c.771C>G)[748,792]+Fluc",c.771C>G,"UAC, p.Tyr275",UAG,IVT_tRNA,liposome,,Ser(AGA),Ser(CUA),,chr6.tRNA151,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(AGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGGCAGGCU(CUA)AACCUGUUGGGGUUUCCCCGCACGGGUUCGAAUCCCGUCGACUACGCCA,,,,,,,NAN,23.02%,rescued rate (protein),,CFRE41o-,not discussed,not discussed,"Investigating the impact of translation rate on readthrough efficiency, by altering the PTC upstream sequence","Bharti, N., Santos, L., Davyt, M. et al. Translation velocity determines the efficacy of engineered suppressor tRNAs on pathogenic nonsense mutations. Nat Commun 15, 2957 (2024). https://doi.org/10.1038/s41467-024-47258-27"
cystic fibrosis,CFTR,fusion protein,Homo sapiens,"ATG+CFTR(c.178G>T)[157,201]+Fluc",c.178G>T,"GAG, p.Glu60",UAG,IVT_tRNA,liposome,,Ser(AGA),Ser(CUA),,chr6.tRNA151,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(AGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGGCAGGCU(CUA)AACCUGUUGGGGUUUCCCCGCACGGGUUCGAAUCCCGUCGACUACGCCA,,,,,,,NAN,4.35%,rescued rate (protein),,CFRE41o-,not discussed,not discussed,"Investigating the impact of translation rate on readthrough efficiency, by altering the PTC upstream sequence","Bharti, N., Santos, L., Davyt, M. et al. Translation velocity determines the efficacy of engineered suppressor tRNAs on pathogenic nonsense mutations. Nat Commun 15, 2957 (2024). https://doi.org/10.1038/s41467-024-47258-28"
cystic fibrosis,CFTR,fusion protein,Homo sapiens,"ATG+CFTR(c.3611G>A,c.3612G>A)[3589,3633]+Fluc","c.3611G>A,c.3612G>A","UGG, p.Trp1204",UAA,IVT_tRNA,liposome,,Ser(AGA),Ser(UUA),,chr6.tRNA151,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(AGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGGCAGGCU(UUA)AACCUGUUGGGGUUUCCCCGCACGGGUUCGAAUCCCGUCGACUACGCCA,,,,,,,NAN,16.31%,rescued rate (protein),,CFRE41o-,not discussed,not discussed,"Investigating the impact of translation rate on readthrough efficiency, by altering the PTC upstream sequence","Bharti, N., Santos, L., Davyt, M. et al. Translation velocity determines the efficacy of engineered suppressor tRNAs on pathogenic nonsense mutations. Nat Commun 15, 2957 (2024). https://doi.org/10.1038/s41467-024-47258-29"
cystic fibrosis,CFTR,fusion protein,Homo sapiens,"ATG+CFTR(c.2537G>A,c.2538G>A)[2515,2559]+Fluc","c.2537G>A,c.2538G>A","UGG, p.Trp846",UAA,IVT_tRNA,liposome,,Ser(AGA),Ser(UUA),,chr6.tRNA151,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(AGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGGCAGGCU(UUA)AACCUGUUGGGGUUUCCCCGCACGGGUUCGAAUCCCGUCGACUACGCCA,,,,,,,NAN,15.83%,rescued rate (protein),,CFRE41o-,not discussed,not discussed,"Investigating the impact of translation rate on readthrough efficiency, by altering the PTC upstream sequence","Bharti, N., Santos, L., Davyt, M. et al. Translation velocity determines the efficacy of engineered suppressor tRNAs on pathogenic nonsense mutations. Nat Commun 15, 2957 (2024). https://doi.org/10.1038/s41467-024-47258-30"
cystic fibrosis,CFTR,fusion protein,Homo sapiens,"ATG+CFTR(c.1397C>A)[1375,1419]+Fluc",c.1397C>A,"UCA, p.Ser466",UAA,IVT_tRNA,liposome,,Ser(AGA),Ser(UUA),,chr6.tRNA151,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(AGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGGCAGGCU(UUA)AACCUGUUGGGGUUUCCCCGCACGGGUUCGAAUCCCGUCGACUACGCCA,,,,,,,NAN,18.94%,rescued rate (protein),,CFRE41o-,not discussed,not discussed,"Investigating the impact of translation rate on readthrough efficiency, by altering the PTC upstream sequence","Bharti, N., Santos, L., Davyt, M. et al. Translation velocity determines the efficacy of engineered suppressor tRNAs on pathogenic nonsense mutations. Nat Commun 15, 2957 (2024). https://doi.org/10.1038/s41467-024-47258-31"
cystic fibrosis,CFTR,fusion protein,Homo sapiens,"ATG+CFTR(c.2143C>T)[2122,2166]+Fluc",c.2143C>T,"CAA, p.Gln715",UAA,IVT_tRNA,liposome,,Ser(AGA),Ser(UUA),,chr6.tRNA151,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(AGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGGCAGGCU(UUA)AACCUGUUGGGGUUUCCCCGCACGGGUUCGAAUCCCGUCGACUACGCCA,,,,,,,NAN,4.97%,rescued rate (protein),,CFRE41o-,not discussed,not discussed,"Investigating the impact of translation rate on readthrough efficiency, by altering the PTC upstream sequence","Bharti, N., Santos, L., Davyt, M. et al. Translation velocity determines the efficacy of engineered suppressor tRNAs on pathogenic nonsense mutations. Nat Commun 15, 2957 (2024). https://doi.org/10.1038/s41467-024-47258-32"
cystic fibrosis,CFTR,fusion protein,Homo sapiens,"ATG+CFTR(c.2053C>T)[2032,2076]+Fluc",c.2053C>T,"CAA, p.Gln685",UAA,IVT_tRNA,liposome,,Ser(AGA),Ser(UUA),,chr6.tRNA151,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(AGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGGCAGGCU(UUA)AACCUGUUGGGGUUUCCCCGCACGGGUUCGAAUCCCGUCGACUACGCCA,,,,,,,NAN,1.38%,rescued rate (protein),,CFRE41o-,not discussed,not discussed,"Investigating the impact of translation rate on readthrough efficiency, by altering the PTC upstream sequence","Bharti, N., Santos, L., Davyt, M. et al. Translation velocity determines the efficacy of engineered suppressor tRNAs on pathogenic nonsense mutations. Nat Commun 15, 2957 (2024). https://doi.org/10.1038/s41467-024-47258-33"
cystic fibrosis,CFTR,fusion protein,Homo sapiens,"ATG+CFTR(c.1466C>A)[1444,1488]+Fluc",c.1466C>A,"UCA, p.Ser489",UAA,IVT_tRNA,liposome,,Ser(AGA),Ser(UUA),,chr6.tRNA151,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(AGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGGCAGGCU(UUA)AACCUGUUGGGGUUUCCCCGCACGGGUUCGAAUCCCGUCGACUACGCCA,,,,,,,NAN,36.66%,rescued rate (protein),,CFRE41o-,not discussed,not discussed,"Investigating the impact of translation rate on readthrough efficiency, by altering the PTC upstream sequence","Bharti, N., Santos, L., Davyt, M. et al. Translation velocity determines the efficacy of engineered suppressor tRNAs on pathogenic nonsense mutations. Nat Commun 15, 2957 (2024). https://doi.org/10.1038/s41467-024-47258-34"
cystic fibrosis,CFTR,fusion protein,Homo sapiens,"ATG+CFTR(c.366T>A)[343,387]+Fluc",c.366T>A,"UAU, p.Tyr122",UAA,IVT_tRNA,liposome,,Ser(AGA),Ser(UUA),,chr6.tRNA151,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(AGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGGCAGGCU(UUA)AACCUGUUGGGGUUUCCCCGCACGGGUUCGAAUCCCGUCGACUACGCCA,,,,,,,NAN,10.78%,rescued rate (protein),,CFRE41o-,not discussed,not discussed,"Investigating the impact of translation rate on readthrough efficiency, by altering the PTC upstream sequence","Bharti, N., Santos, L., Davyt, M. et al. Translation velocity determines the efficacy of engineered suppressor tRNAs on pathogenic nonsense mutations. Nat Commun 15, 2957 (2024). https://doi.org/10.1038/s41467-024-47258-35"
cystic fibrosis,CFTR,fusion protein,Homo sapiens,"ATG+CFTR(c.4231C>T)[4210,4254]+Fluc",c.4231C>T,"CAA, p.Gln1411",UAA,IVT_tRNA,liposome,,Ser(AGA),Ser(UUA),,chr6.tRNA151,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(AGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGGCAGGCU(UUA)AACCUGUUGGGGUUUCCCCGCACGGGUUCGAAUCCCGUCGACUACGCCA,,,,,,,NAN,3.01%,rescued rate (protein),,CFRE41o-,not discussed,not discussed,"Investigating the impact of translation rate on readthrough efficiency, by altering the PTC upstream sequence","Bharti, N., Santos, L., Davyt, M. et al. Translation velocity determines the efficacy of engineered suppressor tRNAs on pathogenic nonsense mutations. Nat Commun 15, 2957 (2024). https://doi.org/10.1038/s41467-024-47258-36"
cystic fibrosis,CFTR,fusion protein,Homo sapiens,"ATG+CFTR(c.1753G>T)[1732,1776]+Fluc",c.1753G>T,"GAA, p.Glu585",UAA,IVT_tRNA,liposome,,Ser(AGA),Ser(UUA),,chr6.tRNA151,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(AGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGGCAGGCU(UUA)AACCUGUUGGGGUUUCCCCGCACGGGUUCGAAUCCCGUCGACUACGCCA,,,,,,,NAN,47.08%,rescued rate (protein),,CFRE41o-,not discussed,not discussed,"Investigating the impact of translation rate on readthrough efficiency, by altering the PTC upstream sequence","Bharti, N., Santos, L., Davyt, M. et al. Translation velocity determines the efficacy of engineered suppressor tRNAs on pathogenic nonsense mutations. Nat Commun 15, 2957 (2024). https://doi.org/10.1038/s41467-024-47258-37"
cystic fibrosis,CFTR,CFTR,Homo sapiens,CFTR(c.3484C>T)[full length],c.3484C>T,"CGA, p.Arg1162",UGA,IVT_tRNA,liposome,,Ser(AGA),Ser(UCA),,chr6.tRNA151,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(AGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGGCAGGCU(UCA)AACCUGUUGGGGUUUCCCCGCACGGGUUCGAAUCCCGUCGACUACGCCA,,,,,,,NAN,217.95%,relative expression,protein expression level relative to negative-control,HEK293,not discussed,not discussed,"Investigating the impact of translation rate on readthrough efficiency, by altering the PTC upstream sequence","Bharti, N., Santos, L., Davyt, M. et al. Translation velocity determines the efficacy of engineered suppressor tRNAs on pathogenic nonsense mutations. Nat Commun 15, 2957 (2024). https://doi.org/10.1038/s41467-024-47258-38"
cystic fibrosis,CFTR,CFTR,Homo sapiens,CFTR(c.3484C>T)[full length],c.3484C>T,"CGA, p.Arg1162",UGA,IVT_tRNA,liposome,,Ser(AGA),Ser(UCA),,chr6.tRNA151,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(AGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGGCAGGCU(UCA)AACCUGUUGGGGUUUCCCCGCACGGGUUCGAAUCCCGUCGACUACGCCA,,,,,,,NAN,597.68%,relative expression,protein expression level relative to negative-control,Hep3B,not discussed,not discussed,"Investigating the impact of translation rate on readthrough efficiency, by altering the PTC upstream sequence","Bharti, N., Santos, L., Davyt, M. et al. Translation velocity determines the efficacy of engineered suppressor tRNAs on pathogenic nonsense mutations. Nat Commun 15, 2957 (2024). https://doi.org/10.1038/s41467-024-47258-39"
primary ciliary dyskinesia (PCD),RSPH4A,fusion protein,Homo sapiens,"ATG+RSPH4A(c.1468C>T)[1447,1491]+Fluc",c.1468C>T,"CGA, p.Arg490",UGA,IVT_tRNA,liposome,,Ser(UGA),Ser(UCA),,chr6.tRNA53,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(UGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGGCAGGCU(UCA)AACCUGUUGGGGUUUCCCCGCACGGGUUCGAAUCCCGUCGACUACGCCA,,,,,,,NAN,7.25%,rescued rate (protein),,CFRE41o-,not discussed,not discussed,"Investigating the impact of translation rate on readthrough efficiency, by altering the PTC upstream sequence","Bharti, N., Santos, L., Davyt, M. et al. Translation velocity determines the efficacy of engineered suppressor tRNAs on pathogenic nonsense mutations. Nat Commun 15, 2957 (2024). https://doi.org/10.1038/s41467-024-47258-9"
primary ciliary dyskinesia (PCD),DNAH5,fusion protein,Homo sapiens,"ATG+DNAH5(c.5131C>T)[5110,5154]+Fluc",c.5131C>T,"CGA, p.Arg1711",UGA,IVT_tRNA,liposome,,Ser(UGA),Ser(UCA),,chr6.tRNA53,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(UGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGGCAGGCU(UCA)AACCUGUUGGGGUUUCCCCGCACGGGUUCGAAUCCCGUCGACUACGCCA,,,,,,,NAN,7.86%,rescued rate (protein),,CFRE41o-,not discussed,not discussed,"Investigating the impact of translation rate on readthrough efficiency, by altering the PTC upstream sequence","Bharti, N., Santos, L., Davyt, M. et al. Translation velocity determines the efficacy of engineered suppressor tRNAs on pathogenic nonsense mutations. Nat Commun 15, 2957 (2024). https://doi.org/10.1038/s41467-024-47258-10"
primary ciliary dyskinesia (PCD),DNAH5,fusion protein,Homo sapiens,"ATG+DNAH5(c.8029C>T)[8008,8052]+Fluc",c.8029C>T,"CGA, p.Arg2677",UGA,IVT_tRNA,liposome,,Ser(UGA),Ser(UCA),,chr6.tRNA53,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(UGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGGCAGGCU(UCA)AACCUGUUGGGGUUUCCCCGCACGGGUUCGAAUCCCGUCGACUACGCCA,,,,,,,NAN,11.71%,rescued rate (protein),,CFRE41o-,not discussed,not discussed,"Investigating the impact of translation rate on readthrough efficiency, by altering the PTC upstream sequence","Bharti, N., Santos, L., Davyt, M. et al. Translation velocity determines the efficacy of engineered suppressor tRNAs on pathogenic nonsense mutations. Nat Commun 15, 2957 (2024). https://doi.org/10.1038/s41467-024-47258-11"
primary ciliary dyskinesia (PCD),DNAH5,fusion protein,Homo sapiens,"ATG+DNAH5(c.5647C>T)[5626,5670]+Fluc",c.5647C>T,"CGA, p.Arg1883",UGA,IVT_tRNA,liposome,,Ser(UGA),Ser(UCA),,chr6.tRNA53,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(UGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGGCAGGCU(UCA)AACCUGUUGGGGUUUCCCCGCACGGGUUCGAAUCCCGUCGACUACGCCA,,,,,,,NAN,3.78%,rescued rate (protein),,CFRE41o-,not discussed,not discussed,"Investigating the impact of translation rate on readthrough efficiency, by altering the PTC upstream sequence","Bharti, N., Santos, L., Davyt, M. et al. Translation velocity determines the efficacy of engineered suppressor tRNAs on pathogenic nonsense mutations. Nat Commun 15, 2957 (2024). https://doi.org/10.1038/s41467-024-47258-12"
cystic fibrosis,CFTR,fusion protein,Homo sapiens,"ATG+CFTR(c.3846G>A)[3823,3867]+Fluc",c.3846G>A,"UGG, p.Trp1282",UGA,IVT_tRNA,liposome,,Ser(UGA),Ser(UCA),,chr6.tRNA53,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(UGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGGCAGGCU(UCA)AACCUGUUGGGGUUUCCCCGCACGGGUUCGAAUCCCGUCGACUACGCCA,,,,,,,NAN,54.79%,rescued rate (protein),,CFRE41o-,not discussed,not discussed,"Investigating the impact of translation rate on readthrough efficiency, by altering the PTC upstream sequence","Bharti, N., Santos, L., Davyt, M. et al. Translation velocity determines the efficacy of engineered suppressor tRNAs on pathogenic nonsense mutations. Nat Commun 15, 2957 (2024). https://doi.org/10.1038/s41467-024-47258-13"
cystic fibrosis,CFTR,fusion protein,Homo sapiens,"ATG+CFTR(c.1657C>T)[1636,1680]+Fluc",c.1657C>T,"CGA, p.Arg553",UGA,IVT_tRNA,liposome,,Ser(UGA),Ser(UCA),,chr6.tRNA53,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(UGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGGCAGGCU(UCA)AACCUGUUGGGGUUUCCCCGCACGGGUUCGAAUCCCGUCGACUACGCCA,,,,,,,NAN,19.43%,rescued rate (protein),,CFRE41o-,not discussed,not discussed,"Investigating the impact of translation rate on readthrough efficiency, by altering the PTC upstream sequence","Bharti, N., Santos, L., Davyt, M. et al. Translation velocity determines the efficacy of engineered suppressor tRNAs on pathogenic nonsense mutations. Nat Commun 15, 2957 (2024). https://doi.org/10.1038/s41467-024-47258-14"
cystic fibrosis,CFTR,fusion protein,Homo sapiens,"ATG+CFTR(c.1624G>T)[1603,1647]+Fluc",c.1624G>T,"GGA, p.Gly542",UGA,IVT_tRNA,liposome,,Ser(UGA),Ser(UCA),,chr6.tRNA53,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(UGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGGCAGGCU(UCA)AACCUGUUGGGGUUUCCCCGCACGGGUUCGAAUCCCGUCGACUACGCCA,,,,,,,NAN,17.29%,rescued rate (protein),,CFRE41o-,not discussed,not discussed,"Investigating the impact of translation rate on readthrough efficiency, by altering the PTC upstream sequence","Bharti, N., Santos, L., Davyt, M. et al. Translation velocity determines the efficacy of engineered suppressor tRNAs on pathogenic nonsense mutations. Nat Commun 15, 2957 (2024). https://doi.org/10.1038/s41467-024-47258-15"
cystic fibrosis,CFTR,fusion protein,Homo sapiens,"ATG+CFTR(-7codons,PTC,+7codons)+Fluc",c.3612G>A,"UGG, p.Trp1204",UGA,IVT_tRNA,liposome,,Ser(UGA),Ser(UCA),,chr6.tRNA53,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(UGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGGCAGGCU(UCA)AACCUGUUGGGGUUUCCCCGCACGGGUUCGAAUCCCGUCGACUACGCCA,,,,,,,NAN,15.74%,rescued rate (protein),,CFRE41o-,not discussed,not discussed,"Investigating the impact of translation rate on readthrough efficiency, by altering the PTC upstream sequence","Bharti, N., Santos, L., Davyt, M. et al. Translation velocity determines the efficacy of engineered suppressor tRNAs on pathogenic nonsense mutations. Nat Commun 15, 2957 (2024). https://doi.org/10.1038/s41467-024-47258-16"
cystic fibrosis,CFTR,fusion protein,Homo sapiens,"ATG+CFTR(c.2538G>A)[2515,2559]+Fluc",c.2538G>A,"UGG, p.Trp846",UGA,IVT_tRNA,liposome,,Ser(UGA),Ser(UCA),,chr6.tRNA53,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(UGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGGCAGGCU(UCA)AACCUGUUGGGGUUUCCCCGCACGGGUUCGAAUCCCGUCGACUACGCCA,,,,,,,NAN,3.99%,rescued rate (protein),,CFRE41o-,not discussed,not discussed,"Investigating the impact of translation rate on readthrough efficiency, by altering the PTC upstream sequence","Bharti, N., Santos, L., Davyt, M. et al. Translation velocity determines the efficacy of engineered suppressor tRNAs on pathogenic nonsense mutations. Nat Commun 15, 2957 (2024). https://doi.org/10.1038/s41467-024-47258-17"
cystic fibrosis,CFTR,fusion protein,Homo sapiens,"ATG+CFTR(c.1397C>G)[1375,1419]+Fluc",c.1397C>G,"UCA, p.Ser466",UGA,IVT_tRNA,liposome,,Ser(UGA),Ser(UCA),,chr6.tRNA53,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(UGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGGCAGGCU(UCA)AACCUGUUGGGGUUUCCCCGCACGGGUUCGAAUCCCGUCGACUACGCCA,,,,,,,NAN,21.71%,rescued rate (protein),,CFRE41o-,not discussed,not discussed,"Investigating the impact of translation rate on readthrough efficiency, by altering the PTC upstream sequence","Bharti, N., Santos, L., Davyt, M. et al. Translation velocity determines the efficacy of engineered suppressor tRNAs on pathogenic nonsense mutations. Nat Commun 15, 2957 (2024). https://doi.org/10.1038/s41467-024-47258-18"
cystic fibrosis,CFTR,fusion protein,Homo sapiens,"ATG+CFTR(c.3484C>T)[3449,3521]+Fluc",c.3484C>T,"CGA, p.Arg1162",UGA,IVT_tRNA,liposome,,Ser(UGA),Ser(UCA),,chr6.tRNA53,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(UGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGGCAGGCU(UCA)AACCUGUUGGGGUUUCCCCGCACGGGUUCGAAUCCCGUCGACUACGCCA,,,,,,,NAN,26.79%,rescued rate (protein),,CFRE41o-,not discussed,not discussed,"Investigating the impact of translation rate on readthrough efficiency, by altering the PTC upstream sequence","Bharti, N., Santos, L., Davyt, M. et al. Translation velocity determines the efficacy of engineered suppressor tRNAs on pathogenic nonsense mutations. Nat Commun 15, 2957 (2024). https://doi.org/10.1038/s41467-024-47258-19"
cystic fibrosis,CFTR,fusion protein,Homo sapiens,"ATG+CFTR(c.1572C>A)[1549,1593]+Fluc",c.1572C>A,"UGC, p.Cys524",UGA,IVT_tRNA,liposome,,Ser(UGA),Ser(UCA),,chr6.tRNA53,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(UGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGGCAGGCU(UCA)AACCUGUUGGGGUUUCCCCGCACGGGUUCGAAUCCCGUCGACUACGCCA,,,,,,,NAN,11.92%,rescued rate (protein),,CFRE41o-,not discussed,not discussed,"Investigating the impact of translation rate on readthrough efficiency, by altering the PTC upstream sequence","Bharti, N., Santos, L., Davyt, M. et al. Translation velocity determines the efficacy of engineered suppressor tRNAs on pathogenic nonsense mutations. Nat Commun 15, 2957 (2024). https://doi.org/10.1038/s41467-024-47258-20"
cystic fibrosis,CFTR,fusion protein,Homo sapiens,"ATG+CFTR(c.3611G>A)[3589,3633]+Fluc",c.3611G>A,"UGG, p.Trp1204",UAG,IVT_tRNA,liposome,,Ser(UGA),Ser(CUA),,chr6.tRNA53,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(UGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGGCAGGCU(CUA)AACCUGUUGGGGUUUCCCCGCACGGGUUCGAAUCCCGUCGACUACGCCA,,,,,,,NAN,4.12%,rescued rate (protein),,CFRE41o-,not discussed,not discussed,"Investigating the impact of translation rate on readthrough efficiency, by altering the PTC upstream sequence","Bharti, N., Santos, L., Davyt, M. et al. Translation velocity determines the efficacy of engineered suppressor tRNAs on pathogenic nonsense mutations. Nat Commun 15, 2957 (2024). https://doi.org/10.1038/s41467-024-47258-21"
cystic fibrosis,CFTR,fusion protein,Homo sapiens,"ATG+CFTR(c.2537G>A)[2515,2559]+Fluc",c.2537G>A,"UGG, p.Trp846",UAG,IVT_tRNA,liposome,,Ser(UGA),Ser(CUA),,chr6.tRNA53,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(UGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGGCAGGCU(CUA)AACCUGUUGGGGUUUCCCCGCACGGGUUCGAAUCCCGUCGACUACGCCA,,,,,,,NAN,-0.20%,rescued rate (protein),,CFRE41o-,not discussed,not discussed,"Investigating the impact of translation rate on readthrough efficiency, by altering the PTC upstream sequence","Bharti, N., Santos, L., Davyt, M. et al. Translation velocity determines the efficacy of engineered suppressor tRNAs on pathogenic nonsense mutations. Nat Commun 15, 2957 (2024). https://doi.org/10.1038/s41467-024-47258-22"
cystic fibrosis,CFTR,fusion protein,Homo sapiens,"ATG+CFTR(c.1397C>A,c.1398A>G)[1375,1419]+Fluc","c.1397C>A,c.1398A>G","UCA, p.Ser466",UAG,IVT_tRNA,liposome,,Ser(UGA),Ser(CUA),,chr6.tRNA53,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(UGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGGCAGGCU(CUA)AACCUGUUGGGGUUUCCCCGCACGGGUUCGAAUCCCGUCGACUACGCCA,,,,,,,NAN,21.61%,rescued rate (protein),,CFRE41o-,not discussed,not discussed,"Investigating the impact of translation rate on readthrough efficiency, by altering the PTC upstream sequence","Bharti, N., Santos, L., Davyt, M. et al. Translation velocity determines the efficacy of engineered suppressor tRNAs on pathogenic nonsense mutations. Nat Commun 15, 2957 (2024). https://doi.org/10.1038/s41467-024-47258-23"
cystic fibrosis,CFTR,fusion protein,Homo sapiens,"ATG+CFTR(c.1477C>T)[1456,1500]+Fluc",c.1477C>T,"CAG, p.Gln493",UAG,IVT_tRNA,liposome,,Ser(UGA),Ser(CUA),,chr6.tRNA53,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(UGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGGCAGGCU(CUA)AACCUGUUGGGGUUUCCCCGCACGGGUUCGAAUCCCGUCGACUACGCCA,,,,,,,NAN,2.99%,rescued rate (protein),,CFRE41o-,not discussed,not discussed,"Investigating the impact of translation rate on readthrough efficiency, by altering the PTC upstream sequence","Bharti, N., Santos, L., Davyt, M. et al. Translation velocity determines the efficacy of engineered suppressor tRNAs on pathogenic nonsense mutations. Nat Commun 15, 2957 (2024). https://doi.org/10.1038/s41467-024-47258-24"
cystic fibrosis,CFTR,fusion protein,Homo sapiens,"ATG+CFTR(c.2437G>T)[2416,2460]+Fluc",c.2437G>T,"GAG, p.Glu813",UAG,IVT_tRNA,liposome,,Ser(UGA),Ser(CUA),,chr6.tRNA53,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(UGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGGCAGGCU(CUA)AACCUGUUGGGGUUUCCCCGCACGGGUUCGAAUCCCGUCGACUACGCCA,,,,,,,NAN,1.41%,rescued rate (protein),,CFRE41o-,not discussed,not discussed,"Investigating the impact of translation rate on readthrough efficiency, by altering the PTC upstream sequence","Bharti, N., Santos, L., Davyt, M. et al. Translation velocity determines the efficacy of engineered suppressor tRNAs on pathogenic nonsense mutations. Nat Commun 15, 2957 (2024). https://doi.org/10.1038/s41467-024-47258-25"
cystic fibrosis,CFTR,fusion protein,Homo sapiens,"ATG+CFTR(c.170G>A)[148,192]+Fluc",c.170G>A,"UGG, p.Trp57",UAG,IVT_tRNA,liposome,,Ser(UGA),Ser(CUA),,chr6.tRNA53,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(UGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGGCAGGCU(CUA)AACCUGUUGGGGUUUCCCCGCACGGGUUCGAAUCCCGUCGACUACGCCA,,,,,,,NAN,19.93%,rescued rate (protein),,CFRE41o-,not discussed,not discussed,"Investigating the impact of translation rate on readthrough efficiency, by altering the PTC upstream sequence","Bharti, N., Santos, L., Davyt, M. et al. Translation velocity determines the efficacy of engineered suppressor tRNAs on pathogenic nonsense mutations. Nat Commun 15, 2957 (2024). https://doi.org/10.1038/s41467-024-47258-26"
cystic fibrosis,CFTR,fusion protein,Homo sapiens,"ATG+CFTR(c.771C>G)[748,792]+Fluc",c.771C>G,"UAC, p.Tyr275",UAG,IVT_tRNA,liposome,,Ser(UGA),Ser(CUA),,chr6.tRNA53,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(UGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGGCAGGCU(CUA)AACCUGUUGGGGUUUCCCCGCACGGGUUCGAAUCCCGUCGACUACGCCA,,,,,,,NAN,23.02%,rescued rate (protein),,CFRE41o-,not discussed,not discussed,"Investigating the impact of translation rate on readthrough efficiency, by altering the PTC upstream sequence","Bharti, N., Santos, L., Davyt, M. et al. Translation velocity determines the efficacy of engineered suppressor tRNAs on pathogenic nonsense mutations. Nat Commun 15, 2957 (2024). https://doi.org/10.1038/s41467-024-47258-27"
cystic fibrosis,CFTR,fusion protein,Homo sapiens,"ATG+CFTR(c.178G>T)[157,201]+Fluc",c.178G>T,"GAG, p.Glu60",UAG,IVT_tRNA,liposome,,Ser(UGA),Ser(CUA),,chr6.tRNA53,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(UGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGGCAGGCU(CUA)AACCUGUUGGGGUUUCCCCGCACGGGUUCGAAUCCCGUCGACUACGCCA,,,,,,,NAN,4.35%,rescued rate (protein),,CFRE41o-,not discussed,not discussed,"Investigating the impact of translation rate on readthrough efficiency, by altering the PTC upstream sequence","Bharti, N., Santos, L., Davyt, M. et al. Translation velocity determines the efficacy of engineered suppressor tRNAs on pathogenic nonsense mutations. Nat Commun 15, 2957 (2024). https://doi.org/10.1038/s41467-024-47258-28"
cystic fibrosis,CFTR,fusion protein,Homo sapiens,"ATG+CFTR(c.3611G>A,c.3612G>A)[3589,3633]+Fluc","c.3611G>A,c.3612G>A","UGG, p.Trp1204",UAA,IVT_tRNA,liposome,,Ser(UGA),Ser(UUA),,chr6.tRNA53,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(UGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGGCAGGCU(UUA)AACCUGUUGGGGUUUCCCCGCACGGGUUCGAAUCCCGUCGACUACGCCA,,,,,,,NAN,16.31%,rescued rate (protein),,CFRE41o-,not discussed,not discussed,"Investigating the impact of translation rate on readthrough efficiency, by altering the PTC upstream sequence","Bharti, N., Santos, L., Davyt, M. et al. Translation velocity determines the efficacy of engineered suppressor tRNAs on pathogenic nonsense mutations. Nat Commun 15, 2957 (2024). https://doi.org/10.1038/s41467-024-47258-29"
cystic fibrosis,CFTR,fusion protein,Homo sapiens,"ATG+CFTR(c.2537G>A,c.2538G>A)[2515,2559]+Fluc","c.2537G>A,c.2538G>A","UGG, p.Trp846",UAA,IVT_tRNA,liposome,,Ser(UGA),Ser(UUA),,chr6.tRNA53,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(UGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGGCAGGCU(UUA)AACCUGUUGGGGUUUCCCCGCACGGGUUCGAAUCCCGUCGACUACGCCA,,,,,,,NAN,15.83%,rescued rate (protein),,CFRE41o-,not discussed,not discussed,"Investigating the impact of translation rate on readthrough efficiency, by altering the PTC upstream sequence","Bharti, N., Santos, L., Davyt, M. et al. Translation velocity determines the efficacy of engineered suppressor tRNAs on pathogenic nonsense mutations. Nat Commun 15, 2957 (2024). https://doi.org/10.1038/s41467-024-47258-30"
cystic fibrosis,CFTR,fusion protein,Homo sapiens,"ATG+CFTR(c.1397C>A)[1375,1419]+Fluc",c.1397C>A,"UCA, p.Ser466",UAA,IVT_tRNA,liposome,,Ser(UGA),Ser(UUA),,chr6.tRNA53,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(UGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGGCAGGCU(UUA)AACCUGUUGGGGUUUCCCCGCACGGGUUCGAAUCCCGUCGACUACGCCA,,,,,,,NAN,18.94%,rescued rate (protein),,CFRE41o-,not discussed,not discussed,"Investigating the impact of translation rate on readthrough efficiency, by altering the PTC upstream sequence","Bharti, N., Santos, L., Davyt, M. et al. Translation velocity determines the efficacy of engineered suppressor tRNAs on pathogenic nonsense mutations. Nat Commun 15, 2957 (2024). https://doi.org/10.1038/s41467-024-47258-31"
cystic fibrosis,CFTR,fusion protein,Homo sapiens,"ATG+CFTR(c.2143C>T)[2122,2166]+Fluc",c.2143C>T,"CAA, p.Gln715",UAA,IVT_tRNA,liposome,,Ser(UGA),Ser(UUA),,chr6.tRNA53,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(UGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGGCAGGCU(UUA)AACCUGUUGGGGUUUCCCCGCACGGGUUCGAAUCCCGUCGACUACGCCA,,,,,,,NAN,4.97%,rescued rate (protein),,CFRE41o-,not discussed,not discussed,"Investigating the impact of translation rate on readthrough efficiency, by altering the PTC upstream sequence","Bharti, N., Santos, L., Davyt, M. et al. Translation velocity determines the efficacy of engineered suppressor tRNAs on pathogenic nonsense mutations. Nat Commun 15, 2957 (2024). https://doi.org/10.1038/s41467-024-47258-32"
cystic fibrosis,CFTR,fusion protein,Homo sapiens,"ATG+CFTR(c.2053C>T)[2032,2076]+Fluc",c.2053C>T,"CAA, p.Gln685",UAA,IVT_tRNA,liposome,,Ser(UGA),Ser(UUA),,chr6.tRNA53,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(UGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGGCAGGCU(UUA)AACCUGUUGGGGUUUCCCCGCACGGGUUCGAAUCCCGUCGACUACGCCA,,,,,,,NAN,1.38%,rescued rate (protein),,CFRE41o-,not discussed,not discussed,"Investigating the impact of translation rate on readthrough efficiency, by altering the PTC upstream sequence","Bharti, N., Santos, L., Davyt, M. et al. Translation velocity determines the efficacy of engineered suppressor tRNAs on pathogenic nonsense mutations. Nat Commun 15, 2957 (2024). https://doi.org/10.1038/s41467-024-47258-33"
cystic fibrosis,CFTR,fusion protein,Homo sapiens,"ATG+CFTR(c.1466C>A)[1444,1488]+Fluc",c.1466C>A,"UCA, p.Ser489",UAA,IVT_tRNA,liposome,,Ser(UGA),Ser(UUA),,chr6.tRNA53,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(UGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGGCAGGCU(UUA)AACCUGUUGGGGUUUCCCCGCACGGGUUCGAAUCCCGUCGACUACGCCA,,,,,,,NAN,36.66%,rescued rate (protein),,CFRE41o-,not discussed,not discussed,"Investigating the impact of translation rate on readthrough efficiency, by altering the PTC upstream sequence","Bharti, N., Santos, L., Davyt, M. et al. Translation velocity determines the efficacy of engineered suppressor tRNAs on pathogenic nonsense mutations. Nat Commun 15, 2957 (2024). https://doi.org/10.1038/s41467-024-47258-34"
cystic fibrosis,CFTR,fusion protein,Homo sapiens,"ATG+CFTR(c.366T>A)[343,387]+Fluc",c.366T>A,"UAU, p.Tyr122",UAA,IVT_tRNA,liposome,,Ser(UGA),Ser(UUA),,chr6.tRNA53,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(UGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGGCAGGCU(UUA)AACCUGUUGGGGUUUCCCCGCACGGGUUCGAAUCCCGUCGACUACGCCA,,,,,,,NAN,10.78%,rescued rate (protein),,CFRE41o-,not discussed,not discussed,"Investigating the impact of translation rate on readthrough efficiency, by altering the PTC upstream sequence","Bharti, N., Santos, L., Davyt, M. et al. Translation velocity determines the efficacy of engineered suppressor tRNAs on pathogenic nonsense mutations. Nat Commun 15, 2957 (2024). https://doi.org/10.1038/s41467-024-47258-35"
cystic fibrosis,CFTR,fusion protein,Homo sapiens,"ATG+CFTR(c.4231C>T)[4210,4254]+Fluc",c.4231C>T,"CAA, p.Gln1411",UAA,IVT_tRNA,liposome,,Ser(UGA),Ser(UUA),,chr6.tRNA53,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(UGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGGCAGGCU(UUA)AACCUGUUGGGGUUUCCCCGCACGGGUUCGAAUCCCGUCGACUACGCCA,,,,,,,NAN,3.01%,rescued rate (protein),,CFRE41o-,not discussed,not discussed,"Investigating the impact of translation rate on readthrough efficiency, by altering the PTC upstream sequence","Bharti, N., Santos, L., Davyt, M. et al. Translation velocity determines the efficacy of engineered suppressor tRNAs on pathogenic nonsense mutations. Nat Commun 15, 2957 (2024). https://doi.org/10.1038/s41467-024-47258-36"
cystic fibrosis,CFTR,fusion protein,Homo sapiens,"ATG+CFTR(c.1753G>T)[1732,1776]+Fluc",c.1753G>T,"GAA, p.Glu585",UAA,IVT_tRNA,liposome,,Ser(UGA),Ser(UUA),,chr6.tRNA53,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(UGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGGCAGGCU(UUA)AACCUGUUGGGGUUUCCCCGCACGGGUUCGAAUCCCGUCGACUACGCCA,,,,,,,NAN,47.08%,rescued rate (protein),,CFRE41o-,not discussed,not discussed,"Investigating the impact of translation rate on readthrough efficiency, by altering the PTC upstream sequence","Bharti, N., Santos, L., Davyt, M. et al. Translation velocity determines the efficacy of engineered suppressor tRNAs on pathogenic nonsense mutations. Nat Commun 15, 2957 (2024). https://doi.org/10.1038/s41467-024-47258-37"
cystic fibrosis,CFTR,CFTR,Homo sapiens,CFTR(c.3484C>T)[full length],c.3484C>T,"CGA, p.Arg1162",UGA,IVT_tRNA,liposome,,Ser(UGA),Ser(UCA),,chr6.tRNA53,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(UGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGGCAGGCU(UCA)AACCUGUUGGGGUUUCCCCGCACGGGUUCGAAUCCCGUCGACUACGCCA,,,,,,,NAN,217.95%,relative expression,protein expression level relative to negative-control,HEK293,not discussed,not discussed,"Investigating the impact of translation rate on readthrough efficiency, by altering the PTC upstream sequence","Bharti, N., Santos, L., Davyt, M. et al. Translation velocity determines the efficacy of engineered suppressor tRNAs on pathogenic nonsense mutations. Nat Commun 15, 2957 (2024). https://doi.org/10.1038/s41467-024-47258-38"
cystic fibrosis,CFTR,CFTR,Homo sapiens,CFTR(c.3484C>T)[full length],c.3484C>T,"CGA, p.Arg1162",UGA,IVT_tRNA,liposome,,Ser(UGA),Ser(UCA),,chr6.tRNA53,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(UGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGGCAGGCU(UCA)AACCUGUUGGGGUUUCCCCGCACGGGUUCGAAUCCCGUCGACUACGCCA,,,,,,,NAN,597.68%,relative expression,protein expression level relative to negative-control,Hep3B,not discussed,not discussed,"Investigating the impact of translation rate on readthrough efficiency, by altering the PTC upstream sequence","Bharti, N., Santos, L., Davyt, M. et al. Translation velocity determines the efficacy of engineered suppressor tRNAs on pathogenic nonsense mutations. Nat Commun 15, 2957 (2024). https://doi.org/10.1038/s41467-024-47258-39"
cystic fibrosis,CFTR,CFTR,Homo sapiens,CFTR(c.3484C>T)[full length],c.3484C>T,"CGA, p.Arg1162",UGA,IVT_tRNA,liposome,,Arg(UCU),Arg(UCA),,chr9.tRNA5,Homo sapiens,GGCUCUGUGGCGCAAUGGAUAGCGCAUUGGACU(UCU)AAUUCAAAGGUUGUGGGUUCGAGUCCCACCAGAGUCGCCA,GGCUCUGUGGCGCAAUGGAUAGCGCAUUGGACU(UCA)AAUUCAAAGGUUACGGGUUCGAGUCCCGUCAGAGUCGCCA,,,,,,,NAN,2699.07%,relative expression,protein expression level relative to negative-control,CFRE41o-,not discussed,not discussed,"Investigating the impact of translation rate on readthrough efficiency, by altering the PTC upstream sequence","Bharti, N., Santos, L., Davyt, M. et al. Translation velocity determines the efficacy of engineered suppressor tRNAs on pathogenic nonsense mutations. Nat Commun 15, 2957 (2024). https://doi.org/10.1038/s41467-024-47258-40"
cystic fibrosis,CFTR,CFTR,Homo sapiens,CFTR(c.3484C>T)[full length],c.3484C>T,"CGA, p.Arg1162",UGA,IVT_tRNA,liposome,,Arg(UCU),Arg(UCA),,chr9.tRNA5,Homo sapiens,GGCUCUGUGGCGCAAUGGAUAGCGCAUUGGACU(UCU)AAUUCAAAGGUUGUGGGUUCGAGUCCCACCAGAGUCGCCA,GGCUCUGUGGCGCAAUGGAUAGCGCAUUGGACU(UCA)AAUUCAAAGGUUACGGGUUCGAGUCCCGUCAGAGUCGCCA,,,,,,,NAN,1601.73%,relative expression,protein expression level relative to negative-control,16HBEge,not discussed,not discussed,"Investigating the impact of translation rate on readthrough efficiency, by altering the PTC upstream sequence","Bharti, N., Santos, L., Davyt, M. et al. Translation velocity determines the efficacy of engineered suppressor tRNAs on pathogenic nonsense mutations. Nat Commun 15, 2957 (2024). https://doi.org/10.1038/s41467-024-47258-41"
cystic fibrosis,CFTR,CFTR,Homo sapiens,CFTR(c.3484C>T)[full length],c.3484C>T,"CGA, p.Arg1162",UGA,IVT_tRNA,liposome,,Arg(UCU),Arg(UCA),,chr9.tRNA5,Homo sapiens,GGCUCUGUGGCGCAAUGGAUAGCGCAUUGGACU(UCU)AAUUCAAAGGUUGUGGGUUCGAGUCCCACCAGAGUCGCCA,GGCUCUGUGGCGCAAUGGAUAGCGCAUUGGACU(UCA)AAUUCAAAGGUUACGGGUUCGAGUCCCGUCAGAGUCGCCA,,,,,,,NAN,146.28%,relative expression,protein expression level relative to negative-control,hNE,not discussed,not discussed,"Investigating the impact of translation rate on readthrough efficiency, by altering the PTC upstream sequence","Bharti, N., Santos, L., Davyt, M. et al. Translation velocity determines the efficacy of engineered suppressor tRNAs on pathogenic nonsense mutations. Nat Commun 15, 2957 (2024). https://doi.org/10.1038/s41467-024-47258-42"
cystic fibrosis,CFTR,fusion protein,Homo sapiens,"ATG+CFTR(c.3846G>A)[3739,3867]+Fluc",c.3846G>A,"UGG, p.Trp1282",UGA,IVT_tRNA,liposome,,Ser(AGA),Ser(UCA),,chr6.tRNA151,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(AGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGGCAGGCU(UCA)AACCUGUUGGGGUUUCCCCGCACGGGUUCGAAUCCCGUCGACUACGCCA,,,,,,,NAN,14.65%,rescued rate (protein),protein expression level relative to positive-control (without PTC),CFRE41o-,not discussed,not discussed,"Investigating the impact of translation rate on readthrough efficiency, by altering the PTC upstream sequence","Bharti, N., Santos, L., Davyt, M. et al. Translation velocity determines the efficacy of engineered suppressor tRNAs on pathogenic nonsense mutations. Nat Commun 15, 2957 (2024). https://doi.org/10.1038/s41467-024-47258-43"
cystic fibrosis,CFTR,fusion protein,Homo sapiens,"ATG+CFTR(c.3741A>T,c.3744A>G,c.3747G>C,c.3757T>C,c.3759G>A,c.3760T>C,c.3771T>C,c.3795A>T,c.3846G>A)[3739,3867]+Fluc",c.3846G>A,"UGG, p.Trp1282",UGA,IVT_tRNA,liposome,,Ser(AGA),Ser(UCA),,chr6.tRNA151,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(AGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGGCAGGCU(UCA)AACCUGUUGGGGUUUCCCCGCACGGGUUCGAAUCCCGUCGACUACGCCA,,,,,,,NAN,28.83%,rescued rate (protein),protein expression level relative to positive-control (without PTC),CFRE41o-,not discussed,not discussed,"Investigating the impact of translation rate on readthrough efficiency, by altering the PTC upstream sequence","Bharti, N., Santos, L., Davyt, M. et al. Translation velocity determines the efficacy of engineered suppressor tRNAs on pathogenic nonsense mutations. Nat Commun 15, 2957 (2024). https://doi.org/10.1038/s41467-024-47258-44"
cystic fibrosis,CFTR,fusion protein,Homo sapiens,"ATG+CFTR(c.3846G>A)[3739,3867]+Fluc",c.3846G>A,"UGG, p.Trp1282",UGA,IVT_tRNA,liposome,,Ser(UGA),Ser(UCA),,chr6.tRNA53,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(UGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGGCAGGCU(UCA)AACCUGUUGGGGUUUCCCCGCACGGGUUCGAAUCCCGUCGACUACGCCA,,,,,,,NAN,14.65%,rescued rate (protein),protein expression level relative to positive-control (without PTC),CFRE41o-,not discussed,not discussed,"Investigating the impact of translation rate on readthrough efficiency, by altering the PTC upstream sequence","Bharti, N., Santos, L., Davyt, M. et al. Translation velocity determines the efficacy of engineered suppressor tRNAs on pathogenic nonsense mutations. Nat Commun 15, 2957 (2024). https://doi.org/10.1038/s41467-024-47258-43"
cystic fibrosis,CFTR,fusion protein,Homo sapiens,"ATG+CFTR(c.3741A>T,c.3744A>G,c.3747G>C,c.3757T>C,c.3759G>A,c.3760T>C,c.3771T>C,c.3795A>T,c.3846G>A)[3739,3867]+Fluc",c.3846G>A,"UGG, p.Trp1282",UGA,IVT_tRNA,liposome,,Ser(UGA),Ser(UCA),,chr6.tRNA53,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(UGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGGCAGGCU(UCA)AACCUGUUGGGGUUUCCCCGCACGGGUUCGAAUCCCGUCGACUACGCCA,,,,,,,NAN,28.83%,rescued rate (protein),protein expression level relative to positive-control (without PTC),CFRE41o-,not discussed,not discussed,"Investigating the impact of translation rate on readthrough efficiency, by altering the PTC upstream sequence","Bharti, N., Santos, L., Davyt, M. et al. Translation velocity determines the efficacy of engineered suppressor tRNAs on pathogenic nonsense mutations. Nat Commun 15, 2957 (2024). https://doi.org/10.1038/s41467-024-47258-44"
Xeroderma pigmentosum,XPA,XPA,Homo sapiens,XPA(c.619C>T)[full length],c.619C>T,"CGA, p.Arg207",UGA,vector,else,FuGENE 6,Arg(UCG),Arg(UCA),URS0000677EA0_9606,chr6.trna3,Homo sapiens,GACCACGUGGCCUAAUGGAUAAGGCGUCUGACU(UCG)GAUCAGAAGAUUGAGGGUUCGAAUCCCUUCGUGGUUA,GACCACGUGGCCUAAUGGAUAAGGCGUCUGACU(UCA)GAUCAGAAGAUUGAGGGUUCGAAUCCCUUCGUGGUUA,,,,,,,NAN,not discussed,else,No assessment of readthrough efficiency was conducted,XP12ROSV,not discussed,completely nonimmunogenic,设计了一种人Arg opal sup-tRNA，并将其表达在含有XPA基因无义突变（R207X）的XP12ROSV细胞中。结果表明，这种抑制性tRNA能够部分恢复细胞对紫外线照射的耐受性，并提高了DNA修复效率。,"Panchal, R. G., Wang, S., McDermott, J. & Link, C. J. Jr. Partial functional correction of xeroderma pigmentosum group A cells by suppressor tRNA. Hum. Gene Ther. 10, 2209–2219 (1999)."
cystic fibrosis,CFTR,CFTR,Homo sapiens,CFTR(c.3484C>T)[full length],c.3484C>T,"CGA, p.Arg1162",UGA,IVT_tRNA,nanoparticle,LNP,Ser(AGA),Ser(UCA),,chr6.tRNA151,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(AGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(UCA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,,,,,,,NAN,6.77,absolute expression,,Hep3B,"high safety (caused no discernible readthrough at endogenous native stop codons, as determined by ribosome profiling)",not discussed,用工程化 tRNA 抑制无义突变：在小鼠静脉和气管内LNP输注IVT sup-tRNASer；在R1162X-CFTR患者囊性纤维化细胞模型和上皮细胞中转染sup-tRNASer和sup-tRNAArg,"Albers, S. et al. Engineered tRNAs suppress nonsense mutations in cells and in vivo. Nature 618, 842–848 (2023)."
cystic fibrosis,CFTR,CFTR,Homo sapiens,CFTR(c.3484C>T)[full length],c.3484C>T,"CGA, p.Arg1162",UGA,IVT_tRNA,nanoparticle,LNP,Ser(UGA),Ser(UCA),,chr6.tRNA53,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(UGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(UCA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,,,,,,,NAN,6.77,absolute expression,,Hep3B,"high safety (caused no discernible readthrough at endogenous native stop codons, as determined by ribosome profiling)",not discussed,用工程化 tRNA 抑制无义突变：在小鼠静脉和气管内LNP输注IVT sup-tRNASer；在R1162X-CFTR患者囊性纤维化细胞模型和上皮细胞中转染sup-tRNASer和sup-tRNAArg,"Albers, S. et al. Engineered tRNAs suppress nonsense mutations in cells and in vivo. Nature 618, 842–848 (2023)."
cystic fibrosis,CFTR,CFTR,Homo sapiens,CFTR(c.3484C>T)[full length],c.3484C>T,"CGA, p.Arg1162",UGA,IVT_tRNA,nanoparticle,LNP,Ser(AGA),Ser(UCA),,chr6.tRNA151,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(AGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGUCU(UCA)AAACCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,,,,,,,NAN,17.08,absolute expression,,Hep3B,"high safety (caused no discernible readthrough at endogenous native stop codons, as determined by ribosome profiling)",not discussed,用工程化 tRNA 抑制无义突变：在小鼠静脉和气管内LNP输注IVT sup-tRNASer；在R1162X-CFTR患者囊性纤维化细胞模型和上皮细胞中转染sup-tRNASer和sup-tRNAArg,"Albers, S. et al. Engineered tRNAs suppress nonsense mutations in cells and in vivo. Nature 618, 842–848 (2023)."
cystic fibrosis,CFTR,CFTR,Homo sapiens,CFTR(c.3484C>T)[full length],c.3484C>T,"CGA, p.Arg1162",UGA,IVT_tRNA,nanoparticle,LNP,Ser(UGA),Ser(UCA),,chr6.tRNA53,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(UGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGUCU(UCA)AAACCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,,,,,,,NAN,17.08,absolute expression,,Hep3B,"high safety (caused no discernible readthrough at endogenous native stop codons, as determined by ribosome profiling)",not discussed,用工程化 tRNA 抑制无义突变：在小鼠静脉和气管内LNP输注IVT sup-tRNASer；在R1162X-CFTR患者囊性纤维化细胞模型和上皮细胞中转染sup-tRNASer和sup-tRNAArg,"Albers, S. et al. Engineered tRNAs suppress nonsense mutations in cells and in vivo. Nature 618, 842–848 (2023)."
cystic fibrosis,CFTR,CFTR,Homo sapiens,CFTR(c.3484C>T)[full length],c.3484C>T,"CGA, p.Arg1162",UGA,IVT_tRNA,nanoparticle,LNP,Ser(AGA),Ser(UCA),,chr6.tRNA151,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(AGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGGCAGGCU(UCA)AACCUGUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,,,,,,,NAN,4.74,absolute expression,,Hep3B,"high safety (caused no discernible readthrough at endogenous native stop codons, as determined by ribosome profiling)",not discussed,用工程化 tRNA 抑制无义突变：在小鼠静脉和气管内LNP输注IVT sup-tRNASer；在R1162X-CFTR患者囊性纤维化细胞模型和上皮细胞中转染sup-tRNASer和sup-tRNAArg,"Albers, S. et al. Engineered tRNAs suppress nonsense mutations in cells and in vivo. Nature 618, 842–848 (2023)."
cystic fibrosis,CFTR,CFTR,Homo sapiens,CFTR(c.3484C>T)[full length],c.3484C>T,"CGA, p.Arg1162",UGA,IVT_tRNA,nanoparticle,LNP,Ser(UGA),Ser(UCA),,chr6.tRNA53,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(UGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGGCAGGCU(UCA)AACCUGUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,,,,,,,NAN,4.74,absolute expression,,Hep3B,"high safety (caused no discernible readthrough at endogenous native stop codons, as determined by ribosome profiling)",not discussed,用工程化 tRNA 抑制无义突变：在小鼠静脉和气管内LNP输注IVT sup-tRNASer；在R1162X-CFTR患者囊性纤维化细胞模型和上皮细胞中转染sup-tRNASer和sup-tRNAArg,"Albers, S. et al. Engineered tRNAs suppress nonsense mutations in cells and in vivo. Nature 618, 842–848 (2023)."
cystic fibrosis,CFTR,CFTR,Homo sapiens,CFTR(c.3484C>T)[full length],c.3484C>T,"CGA, p.Arg1162",UGA,IVT_tRNA,nanoparticle,LNP,Ser(AGA),Ser(UCA),,chr6.tRNA151,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(AGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(UCA)AAUCCAUUGGGGUUUCCCCGCGCCGGUUCGAAUCCGGCCGACUACGCCA,,,,,,,NAN,6,absolute expression,,Hep3B,"high safety (caused no discernible readthrough at endogenous native stop codons, as determined by ribosome profiling)",not discussed,用工程化 tRNA 抑制无义突变：在小鼠静脉和气管内LNP输注IVT sup-tRNASer；在R1162X-CFTR患者囊性纤维化细胞模型和上皮细胞中转染sup-tRNASer和sup-tRNAArg,"Albers, S. et al. Engineered tRNAs suppress nonsense mutations in cells and in vivo. Nature 618, 842–848 (2023)."
cystic fibrosis,CFTR,CFTR,Homo sapiens,CFTR(c.3484C>T)[full length],c.3484C>T,"CGA, p.Arg1162",UGA,IVT_tRNA,nanoparticle,LNP,Ser(UGA),Ser(UCA),,chr6.tRNA53,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(UGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(UCA)AAUCCAUUGGGGUUUCCCCGCGCCGGUUCGAAUCCGGCCGACUACGCCA,,,,,,,NAN,6,absolute expression,,Hep3B,"high safety (caused no discernible readthrough at endogenous native stop codons, as determined by ribosome profiling)",not discussed,用工程化 tRNA 抑制无义突变：在小鼠静脉和气管内LNP输注IVT sup-tRNASer；在R1162X-CFTR患者囊性纤维化细胞模型和上皮细胞中转染sup-tRNASer和sup-tRNAArg,"Albers, S. et al. Engineered tRNAs suppress nonsense mutations in cells and in vivo. Nature 618, 842–848 (2023)."
cystic fibrosis,CFTR,CFTR,Homo sapiens,CFTR(c.3484C>T)[full length],c.3484C>T,"CGA, p.Arg1162",UGA,IVT_tRNA,nanoparticle,LNP,Ser(AGA),Ser(UCA),,chr6.tRNA151,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(AGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(UCA)AAUCCAUUGGGGUUUCCCCGCCCGGGUUCGAAUCCCGGCGACUACGCCA,,,,,,,NAN,20.31,absolute expression,,Hep3B,"high safety (caused no discernible readthrough at endogenous native stop codons, as determined by ribosome profiling)",not discussed,用工程化 tRNA 抑制无义突变：在小鼠静脉和气管内LNP输注IVT sup-tRNASer；在R1162X-CFTR患者囊性纤维化细胞模型和上皮细胞中转染sup-tRNASer和sup-tRNAArg,"Albers, S. et al. Engineered tRNAs suppress nonsense mutations in cells and in vivo. Nature 618, 842–848 (2023)."
cystic fibrosis,CFTR,CFTR,Homo sapiens,CFTR(c.3484C>T)[full length],c.3484C>T,"CGA, p.Arg1162",UGA,IVT_tRNA,nanoparticle,LNP,Ser(UGA),Ser(UCA),,chr6.tRNA53,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(UGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(UCA)AAUCCAUUGGGGUUUCCCCGCCCGGGUUCGAAUCCCGGCGACUACGCCA,,,,,,,NAN,20.31,absolute expression,,Hep3B,"high safety (caused no discernible readthrough at endogenous native stop codons, as determined by ribosome profiling)",not discussed,用工程化 tRNA 抑制无义突变：在小鼠静脉和气管内LNP输注IVT sup-tRNASer；在R1162X-CFTR患者囊性纤维化细胞模型和上皮细胞中转染sup-tRNASer和sup-tRNAArg,"Albers, S. et al. Engineered tRNAs suppress nonsense mutations in cells and in vivo. Nature 618, 842–848 (2023)."
cystic fibrosis,CFTR,CFTR,Homo sapiens,CFTR(c.3484C>T)[full length],c.3484C>T,"CGA, p.Arg1162",UGA,IVT_tRNA,nanoparticle,LNP,Ser(AGA),Ser(UCA),,chr6.tRNA151,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(AGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(UCA)AAUCCAUUGGGGUUUCCCCGCAGGCCUUCGAAUGGCCUCGACUACGCCA,,,,,,,NAN,3.46,absolute expression,,Hep3B,"high safety (caused no discernible readthrough at endogenous native stop codons, as determined by ribosome profiling)",not discussed,用工程化 tRNA 抑制无义突变：在小鼠静脉和气管内LNP输注IVT sup-tRNASer；在R1162X-CFTR患者囊性纤维化细胞模型和上皮细胞中转染sup-tRNASer和sup-tRNAArg,"Albers, S. et al. Engineered tRNAs suppress nonsense mutations in cells and in vivo. Nature 618, 842–848 (2023)."
cystic fibrosis,CFTR,CFTR,Homo sapiens,CFTR(c.3484C>T)[full length],c.3484C>T,"CGA, p.Arg1162",UGA,IVT_tRNA,nanoparticle,LNP,Ser(UGA),Ser(UCA),,chr6.tRNA53,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(UGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(UCA)AAUCCAUUGGGGUUUCCCCGCAGGCCUUCGAAUGGCCUCGACUACGCCA,,,,,,,NAN,3.46,absolute expression,,Hep3B,"high safety (caused no discernible readthrough at endogenous native stop codons, as determined by ribosome profiling)",not discussed,用工程化 tRNA 抑制无义突变：在小鼠静脉和气管内LNP输注IVT sup-tRNASer；在R1162X-CFTR患者囊性纤维化细胞模型和上皮细胞中转染sup-tRNASer和sup-tRNAArg,"Albers, S. et al. Engineered tRNAs suppress nonsense mutations in cells and in vivo. Nature 618, 842–848 (2023)."
cystic fibrosis,CFTR,CFTR,Homo sapiens,CFTR(c.3484C>T)[full length],c.3484C>T,"CGA, p.Arg1162",UGA,IVT_tRNA,nanoparticle,LNP,Ser(AGA),Ser(UCA),,chr6.tRNA151,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(AGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(UCA)AAUCCAUUGGGGUUUCCCCGCGCGGGUUCGAAUCCCGCCGACUACGCCA,,,,,,,NAN,9.23,absolute expression,,Hep3B,"high safety (caused no discernible readthrough at endogenous native stop codons, as determined by ribosome profiling)",not discussed,用工程化 tRNA 抑制无义突变：在小鼠静脉和气管内LNP输注IVT sup-tRNASer；在R1162X-CFTR患者囊性纤维化细胞模型和上皮细胞中转染sup-tRNASer和sup-tRNAArg,"Albers, S. et al. Engineered tRNAs suppress nonsense mutations in cells and in vivo. Nature 618, 842–848 (2023)."
cystic fibrosis,CFTR,CFTR,Homo sapiens,CFTR(c.3484C>T)[full length],c.3484C>T,"CGA, p.Arg1162",UGA,IVT_tRNA,nanoparticle,LNP,Ser(UGA),Ser(UCA),,chr6.tRNA53,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(UGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(UCA)AAUCCAUUGGGGUUUCCCCGCGCGGGUUCGAAUCCCGCCGACUACGCCA,,,,,,,NAN,9.23,absolute expression,,Hep3B,"high safety (caused no discernible readthrough at endogenous native stop codons, as determined by ribosome profiling)",not discussed,用工程化 tRNA 抑制无义突变：在小鼠静脉和气管内LNP输注IVT sup-tRNASer；在R1162X-CFTR患者囊性纤维化细胞模型和上皮细胞中转染sup-tRNASer和sup-tRNAArg,"Albers, S. et al. Engineered tRNAs suppress nonsense mutations in cells and in vivo. Nature 618, 842–848 (2023)."
cystic fibrosis,CFTR,CFTR,Homo sapiens,CFTR(c.3484C>T)[full length],c.3484C>T,"CGA, p.Arg1162",UGA,IVT_tRNA,nanoparticle,LNP,Ser(AGA),Ser(UCA),,chr6.tRNA151,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(AGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(UCA)AAUCCAUUGGGGUUUCCCCGCACGGGUUCGAAUCCCGUCGACUACGCCA,,,,,,,NAN,26.57,absolute expression,,Hep3B,"high safety (caused no discernible readthrough at endogenous native stop codons, as determined by ribosome profiling)",not discussed,用工程化 tRNA 抑制无义突变：在小鼠静脉和气管内LNP输注IVT sup-tRNASer；在R1162X-CFTR患者囊性纤维化细胞模型和上皮细胞中转染sup-tRNASer和sup-tRNAArg,"Albers, S. et al. Engineered tRNAs suppress nonsense mutations in cells and in vivo. Nature 618, 842–848 (2023)."
cystic fibrosis,CFTR,CFTR,Homo sapiens,CFTR(c.3484C>T)[full length],c.3484C>T,"CGA, p.Arg1162",UGA,IVT_tRNA,nanoparticle,LNP,Ser(UGA),Ser(UCA),,chr6.tRNA53,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(UGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(UCA)AAUCCAUUGGGGUUUCCCCGCACGGGUUCGAAUCCCGUCGACUACGCCA,,,,,,,NAN,26.57,absolute expression,,Hep3B,"high safety (caused no discernible readthrough at endogenous native stop codons, as determined by ribosome profiling)",not discussed,用工程化 tRNA 抑制无义突变：在小鼠静脉和气管内LNP输注IVT sup-tRNASer；在R1162X-CFTR患者囊性纤维化细胞模型和上皮细胞中转染sup-tRNASer和sup-tRNAArg,"Albers, S. et al. Engineered tRNAs suppress nonsense mutations in cells and in vivo. Nature 618, 842–848 (2023)."
cystic fibrosis,CFTR,CFTR,Homo sapiens,CFTR(c.3484C>T)[full length],c.3484C>T,"CGA, p.Arg1162",UGA,IVT_tRNA,nanoparticle,LNP,Ser(AGA),Ser(UCA),,chr6.tRNA151,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(AGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(UCA)AAUCCAUUGGGGUUUCCCCGCGCGGGUUCGAAUCCCGUCGACUACGCCA,,,,,,,NAN,9.59,absolute expression,,Hep3B,"high safety (caused no discernible readthrough at endogenous native stop codons, as determined by ribosome profiling)",not discussed,用工程化 tRNA 抑制无义突变：在小鼠静脉和气管内LNP输注IVT sup-tRNASer；在R1162X-CFTR患者囊性纤维化细胞模型和上皮细胞中转染sup-tRNASer和sup-tRNAArg,"Albers, S. et al. Engineered tRNAs suppress nonsense mutations in cells and in vivo. Nature 618, 842–848 (2023)."
cystic fibrosis,CFTR,CFTR,Homo sapiens,CFTR(c.3484C>T)[full length],c.3484C>T,"CGA, p.Arg1162",UGA,IVT_tRNA,nanoparticle,LNP,Ser(UGA),Ser(UCA),,chr6.tRNA53,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(UGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(UCA)AAUCCAUUGGGGUUUCCCCGCGCGGGUUCGAAUCCCGUCGACUACGCCA,,,,,,,NAN,9.59,absolute expression,,Hep3B,"high safety (caused no discernible readthrough at endogenous native stop codons, as determined by ribosome profiling)",not discussed,用工程化 tRNA 抑制无义突变：在小鼠静脉和气管内LNP输注IVT sup-tRNASer；在R1162X-CFTR患者囊性纤维化细胞模型和上皮细胞中转染sup-tRNASer和sup-tRNAArg,"Albers, S. et al. Engineered tRNAs suppress nonsense mutations in cells and in vivo. Nature 618, 842–848 (2023)."
cystic fibrosis,CFTR,CFTR,Homo sapiens,CFTR(c.3484C>T)[full length],c.3484C>T,"CGA, p.Arg1162",UGA,IVT_tRNA,nanoparticle,LNP,Ser(AGA),Ser(UCA),,chr6.tRNA151,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(AGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGUCU(UCA)AAACCAUUGGGGUUUCCCCGCGCGGGUUCGAAUCCCGCCGACUACGCCA,,,,,,,NAN,17.76,absolute expression,,Hep3B,"high safety (caused no discernible readthrough at endogenous native stop codons, as determined by ribosome profiling)",not discussed,用工程化 tRNA 抑制无义突变：在小鼠静脉和气管内LNP输注IVT sup-tRNASer；在R1162X-CFTR患者囊性纤维化细胞模型和上皮细胞中转染sup-tRNASer和sup-tRNAArg,"Albers, S. et al. Engineered tRNAs suppress nonsense mutations in cells and in vivo. Nature 618, 842–848 (2023)."
cystic fibrosis,CFTR,CFTR,Homo sapiens,CFTR(c.3484C>T)[full length],c.3484C>T,"CGA, p.Arg1162",UGA,IVT_tRNA,nanoparticle,LNP,Ser(UGA),Ser(UCA),,chr6.tRNA53,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(UGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGUCU(UCA)AAACCAUUGGGGUUUCCCCGCGCGGGUUCGAAUCCCGCCGACUACGCCA,,,,,,,NAN,17.76,absolute expression,,Hep3B,"high safety (caused no discernible readthrough at endogenous native stop codons, as determined by ribosome profiling)",not discussed,用工程化 tRNA 抑制无义突变：在小鼠静脉和气管内LNP输注IVT sup-tRNASer；在R1162X-CFTR患者囊性纤维化细胞模型和上皮细胞中转染sup-tRNASer和sup-tRNAArg,"Albers, S. et al. Engineered tRNAs suppress nonsense mutations in cells and in vivo. Nature 618, 842–848 (2023)."
cystic fibrosis,CFTR,CFTR,Homo sapiens,CFTR(c.3484C>T)[full length],c.3484C>T,"CGA, p.Arg1162",UGA,IVT_tRNA,nanoparticle,LNP,Ser(AGA),Ser(UCA),,chr6.tRNA151,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(AGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGUCU(UCA)AAACCAUUGGGGUUUCCCCGCACGGGUUCGAAUCCCGUCGACUACGCCA,,,,,,,NAN,19.53,absolute expression,,Hep3B,"high safety (caused no discernible readthrough at endogenous native stop codons, as determined by ribosome profiling)",not discussed,用工程化 tRNA 抑制无义突变：在小鼠静脉和气管内LNP输注IVT sup-tRNASer；在R1162X-CFTR患者囊性纤维化细胞模型和上皮细胞中转染sup-tRNASer和sup-tRNAArg,"Albers, S. et al. Engineered tRNAs suppress nonsense mutations in cells and in vivo. Nature 618, 842–848 (2023)."
cystic fibrosis,CFTR,CFTR,Homo sapiens,CFTR(c.3484C>T)[full length],c.3484C>T,"CGA, p.Arg1162",UGA,IVT_tRNA,nanoparticle,LNP,Ser(UGA),Ser(UCA),,chr6.tRNA53,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(UGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGUCU(UCA)AAACCAUUGGGGUUUCCCCGCACGGGUUCGAAUCCCGUCGACUACGCCA,,,,,,,NAN,19.53,absolute expression,,Hep3B,"high safety (caused no discernible readthrough at endogenous native stop codons, as determined by ribosome profiling)",not discussed,用工程化 tRNA 抑制无义突变：在小鼠静脉和气管内LNP输注IVT sup-tRNASer；在R1162X-CFTR患者囊性纤维化细胞模型和上皮细胞中转染sup-tRNASer和sup-tRNAArg,"Albers, S. et al. Engineered tRNAs suppress nonsense mutations in cells and in vivo. Nature 618, 842–848 (2023)."
cystic fibrosis,CFTR,CFTR,Homo sapiens,CFTR(c.3484C>T)[full length],c.3484C>T,"CGA, p.Arg1162",UGA,IVT_tRNA,nanoparticle,LNP,Ser(AGA),Ser(UCA),,chr6.tRNA151,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(AGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGUCU(UCA)AAACCAUUGGGGUUUCCCCGCGCGGGUUCGAAUCCCGUCGACUACGCCA,,,,,,,NAN,9.01,absolute expression,,Hep3B,"high safety (caused no discernible readthrough at endogenous native stop codons, as determined by ribosome profiling)",not discussed,用工程化 tRNA 抑制无义突变：在小鼠静脉和气管内LNP输注IVT sup-tRNASer；在R1162X-CFTR患者囊性纤维化细胞模型和上皮细胞中转染sup-tRNASer和sup-tRNAArg,"Albers, S. et al. Engineered tRNAs suppress nonsense mutations in cells and in vivo. Nature 618, 842–848 (2023)."
cystic fibrosis,CFTR,CFTR,Homo sapiens,CFTR(c.3484C>T)[full length],c.3484C>T,"CGA, p.Arg1162",UGA,IVT_tRNA,nanoparticle,LNP,Ser(UGA),Ser(UCA),,chr6.tRNA53,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(UGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGUCU(UCA)AAACCAUUGGGGUUUCCCCGCGCGGGUUCGAAUCCCGUCGACUACGCCA,,,,,,,NAN,9.01,absolute expression,,Hep3B,"high safety (caused no discernible readthrough at endogenous native stop codons, as determined by ribosome profiling)",not discussed,用工程化 tRNA 抑制无义突变：在小鼠静脉和气管内LNP输注IVT sup-tRNASer；在R1162X-CFTR患者囊性纤维化细胞模型和上皮细胞中转染sup-tRNASer和sup-tRNAArg,"Albers, S. et al. Engineered tRNAs suppress nonsense mutations in cells and in vivo. Nature 618, 842–848 (2023)."
cystic fibrosis,CFTR,CFTR,Homo sapiens,CFTR(c.3484C>T)[full length],c.3484C>T,"CGA, p.Arg1162",UGA,IVT_tRNA,nanoparticle,LNP,Ser(AGA),Ser(UCA),,chr6.tRNA151,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(AGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGGCAGGCU(UCA)AACCUGUUGGGGUUUCCCCGCACGGGUUCGAAUCCCGUCGACUACGCCA,,,,,,,NAN,22.48,absolute expression,,Hep3B,"high safety (caused no discernible readthrough at endogenous native stop codons, as determined by ribosome profiling)",activate hTLR7 (induce 1.00 pg/mL IL-8); activate hTLR8 (induce 31.05 pg/mL IL-8),用工程化 tRNA 抑制无义突变：在小鼠静脉和气管内LNP输注IVT sup-tRNASer；在R1162X-CFTR患者囊性纤维化细胞模型和上皮细胞中转染sup-tRNASer和sup-tRNAArg,"Albers, S. et al. Engineered tRNAs suppress nonsense mutations in cells and in vivo. Nature 618, 842–848 (2023)."
cystic fibrosis,CFTR,CFTR,Homo sapiens,CFTR(c.3484C>T)[full length],c.3484C>T,"CGA, p.Arg1162",UGA,IVT_tRNA,nanoparticle,LNP,Ser(UGA),Ser(UCA),,chr6.tRNA53,Homo sapiens,GUAGUCGUGGCCGAGUGGUUAAGGCGAUGGACU(UGA)AAUCCAUUGGGGUUUCCCCGCGCAGGUUCGAAUCCUGCCGACUACGCCA,GUAGUCGUGGCCGAGUGGUUAAGGCGGCAGGCU(UCA)AACCUGUUGGGGUUUCCCCGCACGGGUUCGAAUCCCGUCGACUACGCCA,,,,,,,NAN,22.48,absolute expression,,Hep3B,"high safety (caused no discernible readthrough at endogenous native stop codons, as determined by ribosome profiling)",not discussed,用工程化 tRNA 抑制无义突变：在小鼠静脉和气管内LNP输注IVT sup-tRNASer；在R1162X-CFTR患者囊性纤维化细胞模型和上皮细胞中转染sup-tRNASer和sup-tRNAArg,"Albers, S. et al. Engineered tRNAs suppress nonsense mutations in cells and in vivo. Nature 618, 842–848 (2023)."
cystic fibrosis,CFTR,CFTR,Homo sapiens,CFTR(c.3484C>T)[full length],c.3484C>T,"CGA, p.Arg1162",UGA,IVT_tRNA,nanoparticle,LNP,Arg(UCU),Arg(UCA),,chr9.tRNA5,Homo sapiens,GGCUCUGUGGCGCAAUGGAUAGCGCAUUGGACU(UCU)AAUUCAAAGGUUGUGGGUUCGAGUCCCACCAGAGUCGCCA,GGCUCUGUGGCGCAAUGGAUAGCGCAUUGGACU(UCA)AAUUCAAAGGUUGUGGGUUCGAGUCCCACCAGAGUCGCCA,,,,,,,NAN,15.11,absolute expression,,Hep3B,"high safety (caused no discernible readthrough at endogenous native stop codons, as determined by ribosome profiling)",not discussed,用工程化 tRNA 抑制无义突变：在小鼠静脉和气管内LNP输注IVT sup-tRNASer；在R1162X-CFTR患者囊性纤维化细胞模型和上皮细胞中转染sup-tRNASer和sup-tRNAArg,"Albers, S. et al. Engineered tRNAs suppress nonsense mutations in cells and in vivo. Nature 618, 842–848 (2023)."
cystic fibrosis,CFTR,CFTR,Homo sapiens,CFTR(c.3484C>T)[full length],c.3484C>T,"CGA, p.Arg1162",UGA,IVT_tRNA,nanoparticle,LNP,Arg(UCU),Arg(UCA),,chr9.tRNA5,Homo sapiens,GGCUCUGUGGCGCAAUGGAUAGCGCAUUGGACU(UCU)AAUUCAAAGGUUGUGGGUUCGAGUCCCACCAGAGUCGCCA,GGCUCUGUGGCGCAAUGGAUAGCGCAGCAGGCU(UCA)AACCUGUAGGUUGUGGGUUCGAGUCCCACCAGAGUCGCCA,,,,,,,NAN,5.34,absolute expression,,Hep3B,"high safety (caused no discernible readthrough at endogenous native stop codons, as determined by ribosome profiling)",not discussed,用工程化 tRNA 抑制无义突变：在小鼠静脉和气管内LNP输注IVT sup-tRNASer；在R1162X-CFTR患者囊性纤维化细胞模型和上皮细胞中转染sup-tRNASer和sup-tRNAArg,"Albers, S. et al. Engineered tRNAs suppress nonsense mutations in cells and in vivo. Nature 618, 842–848 (2023)."
cystic fibrosis,CFTR,CFTR,Homo sapiens,CFTR(c.3484C>T)[full length],c.3484C>T,"CGA, p.Arg1162",UGA,IVT_tRNA,nanoparticle,LNP,Arg(UCU),Arg(UCA),,chr9.tRNA5,Homo sapiens,GGCUCUGUGGCGCAAUGGAUAGCGCAUUGGACU(UCU)AAUUCAAAGGUUGUGGGUUCGAGUCCCACCAGAGUCGCCA,GGCUCUGUGGCGCAAUGGAUAGCGCAUUGGACU(UCA)AAUUCAAAGGUUACGGGUUCGAGUCCCGUCAGAGUCGCCA,,,,,,,NAN,18.87,absolute expression,,Hep3B,"high safety (caused no discernible readthrough at endogenous native stop codons, as determined by ribosome profiling)",not discussed,用工程化 tRNA 抑制无义突变：在小鼠静脉和气管内LNP输注IVT sup-tRNASer；在R1162X-CFTR患者囊性纤维化细胞模型和上皮细胞中转染sup-tRNASer和sup-tRNAArg,"Albers, S. et al. Engineered tRNAs suppress nonsense mutations in cells and in vivo. Nature 618, 842–848 (2023)."
cystic fibrosis,CFTR,CFTR,Homo sapiens,CFTR(c.3484C>T)[full length],c.3484C>T,"CGA, p.Arg1162",UGA,IVT_tRNA,nanoparticle,LNP,Arg(UCU),Arg(UCA),,chr9.tRNA5,Homo sapiens,GGCUCUGUGGCGCAAUGGAUAGCGCAUUGGACU(UCU)AAUUCAAAGGUUGUGGGUUCGAGUCCCACCAGAGUCGCCA,GGCUCUGUGGCGCAAUGGAUAGCGCAUUGGACU(UCA)AAUUCAAAGGUUGCGGGUUCGAGUCCCGUCAGAGUCGCCA,,,,,,,NAN,26.87,absolute expression,,Hep3B,"high safety (caused no discernible readthrough at endogenous native stop codons, as determined by ribosome profiling)",not discussed,用工程化 tRNA 抑制无义突变：在小鼠静脉和气管内LNP输注IVT sup-tRNASer；在R1162X-CFTR患者囊性纤维化细胞模型和上皮细胞中转染sup-tRNASer和sup-tRNAArg,"Albers, S. et al. Engineered tRNAs suppress nonsense mutations in cells and in vivo. Nature 618, 842–848 (2023)."
cystic fibrosis,CFTR,CFTR,Homo sapiens,CFTR(c.3484C>T)[full length],c.3484C>T,"CGA, p.Arg1162",UGA,IVT_tRNA,nanoparticle,LNP,Arg(UCU),Arg(UCA),,chr9.tRNA5,Homo sapiens,GGCUCUGUGGCGCAAUGGAUAGCGCAUUGGACU(UCU)AAUUCAAAGGUUGUGGGUUCGAGUCCCACCAGAGUCGCCA,GGCUCUGUGGCGCAAUGGAUAGCGCAUUGGACU(UCA)AAUUCAAAGGUUAUGGGUUCGAGUCCCAUCAGAGUCGCCA,,,,,,,NAN,6.53,absolute expression,,Hep3B,"high safety (caused no discernible readthrough at endogenous native stop codons, as determined by ribosome profiling)",not discussed,用工程化 tRNA 抑制无义突变：在小鼠静脉和气管内LNP输注IVT sup-tRNASer；在R1162X-CFTR患者囊性纤维化细胞模型和上皮细胞中转染sup-tRNASer和sup-tRNAArg,"Albers, S. et al. Engineered tRNAs suppress nonsense mutations in cells and in vivo. Nature 618, 842–848 (2023)."
cystic fibrosis,CFTR,CFTR,Homo sapiens,CFTR(c.3484C>T)[full length],c.3484C>T,"CGA, p.Arg1162",UGA,IVT_tRNA,nanoparticle,LNP,Arg(UCU),Arg(UCA),,chr9.tRNA5,Homo sapiens,GGCUCUGUGGCGCAAUGGAUAGCGCAUUGGACU(UCU)AAUUCAAAGGUUGUGGGUUCGAGUCCCACCAGAGUCGCCA,GGCUCUGUGGCGCAAUGGAUAGCGCAUUGGACU(UCA)AAUUCAAAGGUUGCGGGUUCGAGUCCCGCCAGAGUCGCCA,,,,,,,NAN,18.48,absolute expression,,Hep3B,"high safety (caused no discernible readthrough at endogenous native stop codons, as determined by ribosome profiling)",not discussed,用工程化 tRNA 抑制无义突变：在小鼠静脉和气管内LNP输注IVT sup-tRNASer；在R1162X-CFTR患者囊性纤维化细胞模型和上皮细胞中转染sup-tRNASer和sup-tRNAArg,"Albers, S. et al. Engineered tRNAs suppress nonsense mutations in cells and in vivo. Nature 618, 842–848 (2023)."
cystic fibrosis,CFTR,CFTR,Homo sapiens,CFTR(c.3484C>T)[full length],c.3484C>T,"CGA, p.Arg1162",UGA,IVT_tRNA,nanoparticle,LNP,Arg(UCU),Arg(UCA),,chr9.tRNA5,Homo sapiens,GGCUCUGUGGCGCAAUGGAUAGCGCAUUGGACU(UCU)AAUUCAAAGGUUGUGGGUUCGAGUCCCACCAGAGUCGCCA,GGCUCUGUGGCGCAAUGGAUAGCGCAUUGGACU(UCA)AAUUCAAAGGUUGUGGGUUCGAGUCCCAUCAGAGUCGCCA,,,,,,,NAN,6.24,absolute expression,,Hep3B,"high safety (caused no discernible readthrough at endogenous native stop codons, as determined by ribosome profiling)",not discussed,用工程化 tRNA 抑制无义突变：在小鼠静脉和气管内LNP输注IVT sup-tRNASer；在R1162X-CFTR患者囊性纤维化细胞模型和上皮细胞中转染sup-tRNASer和sup-tRNAArg,"Albers, S. et al. Engineered tRNAs suppress nonsense mutations in cells and in vivo. Nature 618, 842–848 (2023)."
cystic fibrosis,CFTR,CFTR,Homo sapiens,CFTR(c.3484C>T)[full length],c.3484C>T,"CGA, p.Arg1162",UGA,IVT_tRNA,nanoparticle,LNP,Arg(UCU),Arg(UCA),,chr9.tRNA5,Homo sapiens,GGCUCUGUGGCGCAAUGGAUAGCGCAUUGGACU(UCU)AAUUCAAAGGUUGUGGGUUCGAGUCCCACCAGAGUCGCCA,GGCUCUGUGGCGCAAUGGAUAGCGCAGCAGGCU(UCA)AACCUGUAGGUUACGGGUUCGAGUCCCGUCAGAGUCGCCA,,,,,,,NAN,not discussed,else,No assessment of readthrough efficiency was conducted,Hep3B,"high safety (caused no discernible readthrough at endogenous native stop codons, as determined by ribosome profiling)",not discussed,用工程化 tRNA 抑制无义突变：在小鼠静脉和气管内LNP输注IVT sup-tRNASer；在R1162X-CFTR患者囊性纤维化细胞模型和上皮细胞中转染sup-tRNASer和sup-tRNAArg,"Albers, S. et al. Engineered tRNAs suppress nonsense mutations in cells and in vivo. Nature 618, 842–848 (2023)."
cystic fibrosis,CFTR,CFTR,Homo sapiens,CFTR(c.3484C>T)[full length],c.3484C>T,"CGA, p.Arg1162",UGA,IVT_tRNA,nanoparticle,LNP,Gly(UCC),Gly(UCA),,chr17.tRNA9,Homo sapiens,GCGUUGGUGGUAUAGUGGUAAGCAUAGCUGCCU(UCC)AAGCAGUUGACCCGGGUUCGAUUCCCGGCCAACGCACCA,GCGUUGGUGGUAUAGUGGUAAGCAUAGCUGCCU(UCA)AAGCAGUUGACCCGGGUUCGAUUCCCGGCCAACGCACCA,,,,,,,NAN,not discussed,else,No assessment of readthrough efficiency was conducted,Hep3B,"high safety (caused no discernible readthrough at endogenous native stop codons, as determined by ribosome profiling)",not discussed,用工程化 tRNA 抑制无义突变：在小鼠静脉和气管内LNP输注IVT sup-tRNASer；在R1162X-CFTR患者囊性纤维化细胞模型和上皮细胞中转染sup-tRNASer和sup-tRNAArg,"Albers, S. et al. Engineered tRNAs suppress nonsense mutations in cells and in vivo. Nature 618, 842–848 (2023)."
cystic fibrosis,CFTR,CFTR,Homo sapiens,CFTR(c.3484C>T)[full length],c.3484C>T,"CGA, p.Arg1162",UGA,IVT_tRNA,nanoparticle,LNP,Gly(UCC),Gly(UCA),,chr17.tRNA9,Homo sapiens,GCGUUGGUGGUAUAGUGGUAAGCAUAGCUGCCU(UCC)AAGCAGUUGACCCGGGUUCGAUUCCCGGCCAACGCACCA,GCGUUGGUGGUAUAGUGGUAAGCAUAGCUGCCU(UCA)AAGCAGUUGACACGGGUUCGAUUCCCGUCCAACGCACCA,,,,,,,NAN,not discussed,else,No assessment of readthrough efficiency was conducted,Hep3B,"high safety (caused no discernible readthrough at endogenous native stop codons, as determined by ribosome profiling)",not discussed,用工程化 tRNA 抑制无义突变：在小鼠静脉和气管内LNP输注IVT sup-tRNASer；在R1162X-CFTR患者囊性纤维化细胞模型和上皮细胞中转染sup-tRNASer和sup-tRNAArg,"Albers, S. et al. Engineered tRNAs suppress nonsense mutations in cells and in vivo. Nature 618, 842–848 (2023)."
cystic fibrosis,CFTR,CFTR,Homo sapiens,CFTR(c.3484C>T)[full length],c.3484C>T,"CGA, p.Arg1162",UGA,IVT_tRNA,nanoparticle,LNP,Gly(UCC),Gly(UCA),,chr17.tRNA9,Homo sapiens,GCGUUGGUGGUAUAGUGGUAAGCAUAGCUGCCU(UCC)AAGCAGUUGACCCGGGUUCGAUUCCCGGCCAACGCACCA,GCGUUGGUGGUAUAGUGGUAAGCAUAGCUGCCU(UCA)AAGCAGUUGACGCGGGUUCGAUUCCCGUCCAACGCACCA,,,,,,,NAN,not discussed,else,No assessment of readthrough efficiency was conducted,Hep3B,"high safety (caused no discernible readthrough at endogenous native stop codons, as determined by ribosome profiling)",not discussed,用工程化 tRNA 抑制无义突变：在小鼠静脉和气管内LNP输注IVT sup-tRNASer；在R1162X-CFTR患者囊性纤维化细胞模型和上皮细胞中转染sup-tRNASer和sup-tRNAArg,"Albers, S. et al. Engineered tRNAs suppress nonsense mutations in cells and in vivo. Nature 618, 842–848 (2023)."
cystic fibrosis,CFTR,CFTR,Homo sapiens,CFTR(c.3484C>T)[full length],c.3484C>T,"CGA, p.Arg1162",UGA,IVT_tRNA,nanoparticle,LNP,Gly(UCC),Gly(UCA),,chr19.tRNA2,Homo sapiens,GCGUUGGUGGUAUAGUGGUUAGCAUAGCUGCCU(UCC)AAGCAGUUGACCCGGGUUCGAUUCCCGGCCAACGCACCA,GCGUUGGUGGUAUAGUGGUUAGCAUAGCUGCCU(UCA)AAGCAGUUGACCCGGGUUCGAUUCCCGGCCAACGCACCA,,,,,,,NAN,not discussed,else,No assessment of readthrough efficiency was conducted,Hep3B,"high safety (caused no discernible readthrough at endogenous native stop codons, as determined by ribosome profiling)",not discussed,用工程化 tRNA 抑制无义突变：在小鼠静脉和气管内LNP输注IVT sup-tRNASer；在R1162X-CFTR患者囊性纤维化细胞模型和上皮细胞中转染sup-tRNASer和sup-tRNAArg,"Albers, S. et al. Engineered tRNAs suppress nonsense mutations in cells and in vivo. Nature 618, 842–848 (2023)."
cystic fibrosis,CFTR,CFTR,Homo sapiens,CFTR(c.3484C>T)[full length],c.3484C>T,"CGA, p.Arg1162",UGA,IVT_tRNA,nanoparticle,LNP,Gly(UCC),Gly(UCA),,chr19.tRNA2,Homo sapiens,GCGUUGGUGGUAUAGUGGUUAGCAUAGCUGCCU(UCC)AAGCAGUUGACCCGGGUUCGAUUCCCGGCCAACGCACCA,GCGUUGGUGGUAUAGUGGUUAGCAUAGCUGCCU(UCA)AAGCAGUUGACACGGGUUCGAUUCCCGUCCAACGCACCA,,,,,,,NAN,not discussed,else,No assessment of readthrough efficiency was conducted,Hep3B,"high safety (caused no discernible readthrough at endogenous native stop codons, as determined by ribosome profiling)",not discussed,用工程化 tRNA 抑制无义突变：在小鼠静脉和气管内LNP输注IVT sup-tRNASer；在R1162X-CFTR患者囊性纤维化细胞模型和上皮细胞中转染sup-tRNASer和sup-tRNAArg,"Albers, S. et al. Engineered tRNAs suppress nonsense mutations in cells and in vivo. Nature 618, 842–848 (2023)."
cystic fibrosis,CFTR,CFTR,Homo sapiens,CFTR(c.3484C>T)[full length],c.3484C>T,"CGA, p.Arg1162",UGA,IVT_tRNA,nanoparticle,LNP,Gly(UCC),Gly(UCA),,chr19.tRNA2,Homo sapiens,GCGUUGGUGGUAUAGUGGUUAGCAUAGCUGCCU(UCC)AAGCAGUUGACCCGGGUUCGAUUCCCGGCCAACGCACCA,GCGUUGGUGGUAUAGUGGUUAGCAUAGCUGCCU(UCA)AAGCAGUUGACGCGGGUUCGAUUCCCGUCCAACGCACCA,,,,,,,NAN,not discussed,else,No assessment of readthrough efficiency was conducted,Hep3B,"high safety (caused no discernible readthrough at endogenous native stop codons, as determined by ribosome profiling)",not discussed,用工程化 tRNA 抑制无义突变：在小鼠静脉和气管内LNP输注IVT sup-tRNASer；在R1162X-CFTR患者囊性纤维化细胞模型和上皮细胞中转染sup-tRNASer和sup-tRNAArg,"Albers, S. et al. Engineered tRNAs suppress nonsense mutations in cells and in vivo. Nature 618, 842–848 (2023)."
